Sports Field 10-Q 19 May 17 2017 Q1 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	3 Months Ended
	Mar. 31, 2017	May 18, 2017
Document and Entity Information [Abstract]
Entity Registrant Name	SPORTS FIELD HOLDINGS, INC.
Entity Central Index Key	1,539,551
Trading Symbol	AGSE
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Document Type	10-Q
Document Period End Date	Mar. 31, 2017
Document Fiscal Period Focus	Q1
Document Fiscal Year Focus	2,017
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding		17,179,510

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($)	Mar. 31, 2017	Dec. 31, 2016
Current Assets
Cash		$ 15,388
Accounts Receivable	445,719	354,159
Costs & Estimated Earnings in Excess of Billings	392,556	75,624
Inventory		110,000
Prepaid Expenses & Other Current Assets	161,636	138,442
Total Current Assets	999,911	693,613
Property, Plant and Equipment, net	9,179	10,193
Deposits	2,090	2,090
TOTAL ASSETS	1,011,180	705,896
Current Liabilities
Cash overdraft	677
Accounts Payable & Accrued Expenses	2,470,913	1,872,981
Billings in Excess of Costs & Estimated Earnings	662,648	374,916
Provision for Estimated Losses on Uncompleted Contracts	33,398	66,079
Current Maturities of Promissory Notes	1,088,020	1,052,410
Derivative Liability	122,400	204,300
Convertible Notes Payable, net	692,668	692,668
Total Current Liabilities	5,070,724	4,263,354
Commitment and Contingencies
Stockholders' Equity (Deficit)
Preferred Stock, $ 0.00001 par value; 20,000,000 shares authorized; none issued and outstanding
Common Stock, $0.00001 par value; 250,000,000 shares authorized, 17,141,583 and 17,074,470 issued and outstanding as of March 31, 2017 and December 31, 2016, respectively	171	171
Paid in Capital	10,437,001	10,404,451
Common Stock Subscription Receivable	(4,500)	(4,500)
Accumulated Deficit	(14,492,216)	(13,957,580)
Total Stockholders' Equity (Deficit)	(4,059,544)	(3,557,458)
TOTAL LIABILITIES & STOCKHOLDERS' EQUITY (DEFICIT)	$ 1,011,180	$ 705,896

Condensed Consolidated Balance3

Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares	Mar. 31, 2017	Dec. 31, 2016
Statement of Financial Position [Abstract]
Preferred stock, par value	$ 0.00001	$ 0.00001
Preferred stock, shares authorized	20,000,000	20,000,000
Preferred stock, shares issued
Preferred stock, shares outstanding
Common stock, par value	$ 0.00001	$ 0.00001
Common stock, shares authorized	250,000,000	250,000,000
Common stock, shares issued	17,141,583	17,074,470
Common stock, shares outstanding	17,141,583	17,074,470

Condensed Consolidated Statemen

Condensed Consolidated Statement of Operations (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Ordinary Income/Expense
Contract Revenue	$ 1,145,744	$ 811,075
Contract Cost of Sales	967,052	763,860
Gross Profit	178,692	47,215
Selling, General and Administrative	750,342	955,204
Research & Development	505	59,773
Depreciation	1,014	1,014
Total Expense	751,861	1,015,991
Loss from Operations	(573,169)	(968,776)
Other Income (Expense)
Interest, net	(71,207)	(159,239)
Gain from Change in Derivative	81,900
Miscellaneous Income	27,840	241
Total Other Income (Expense)	38,533	(158,998)
Loss Before Income Taxes	$ (534,636)	$ (1,127,774)
Net loss per common share, basic and diluted	$ (0.03)	$ (0.08)
Weighted average common shares, basic and diluted	17,110,401	14,816,690

Condensed Consolidated Stateme5

Condensed Consolidated Statements of Cash Flow (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
CASH FLOWS FROM OPERATING ACTIVITIES
Net Loss	$ (534,636)	$ (1,127,774)
Adjustments to reconcile
Depreciation	1,014	1,014
Amortization of debt issuance cost	6,582	23,037
Amortization of debt discount		69,520
Accretion of Original Issue Discount		2,010
Common stock and options issued to consultants and employees	32,549	557,071
Gain on derivative	(81,900)
Changes in Operating Assets and Liabilities:
Cash overdraft	677	1,767
Accounts receivable	(91,560)	(216,047)
Inventory	110,000
Prepaid expense	62,438	(57,159)
Accounts payable and accrued expenses	597,933	(38,743)
Costs and estimated earnings in excess of billings	(316,932)	(15,517)
Billings in excess of costs	287,732	13,149
Provision for estimated losses on uncompleted contracts	(32,681)	(16,682)
Net cash provided by (used in) operating activities	41,216	(804,354)
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds of convertible notes		150,000
Repayments of convertible notes		(150,000)
Repayments of promissory notes	(56,604)	(141,387)
Proceeds from common stock subscriptions		884,341
Net cash provided by (used in) financing activities	(56,604)	742,954
Decrease in cash	(15,388)	(61,400)
Cash, beginning of period	15,388	61,400
Cash, end of period
Cash paid during the period for:
Interest	38,607	47,372
Taxes
Non-cash Investing and financing activities:
Notes issued for insurance premiums	85,632	94,706
Debt discount - beneficial conversion feature		67,637
Debt discount paid in form of common shares		80,137
Stock issuance costs paid in the form of warrants		41,340
Increase in principal amount of convertible notes in connection with debt modification		$ 40,500

Description of Business

Description of Business	3 Months Ended
	Mar. 31, 2017
Description of Business [Abstract]
DESCRIPTION OF BUSINESS	NOTE 1 – DESCRIPTION OF BUSINESS Sports Field Holdings, Inc. (the “Company”, “Sports Field Holdings”, “we”, “our”, or “us”) is a Nevada corporation engaged in product development, engineering, manufacturing, and the construction, design and building of athletic facilities, as well as supplying its own proprietary high end synthetic turf products to the sports industry. The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information. Accordingly, they do not include all of the information and disclosures required by GAAP for annual financial statements. In the opinion of management, such statements include all adjustments (consisting only of normal recurring items) which are considered necessary for a fair presentation of the condensed financial position of the Company as of March 31, 2017, and the results of operations for the three months ended March 31, 2017 and cash flows for the three months ended March 31, 2017. The results of operations for the three ended March 31, 2017 are not necessarily indicative of the operating results for the full year ending December 31, 2017 or any other period. These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and related disclosures of the Company as of December 31, 2016 and for the year then ended, which were filed with the Securities and Exchange Commission (“SEC”) on Form 10-K on March 31, 2017.

Significant Accounting Policies

Significant Accounting Policies	3 Months Ended
	Mar. 31, 2017
Significant Accounting Policies [Abstract]
SIGNIFICANT ACCOUNTING POLICIES	NOTE 2 – SIGNIFICANT ACCOUNTING POLICIES Principles of Consolidation The accompanying condensed consolidated financial statements include the accounts of Sports Field Holdings, Inc. and its wholly owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation. Use of Estimates The preparation of condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenue and expenses during the periods. Actual results could differ from those estimates. The Company’s significant estimates and assumptions include the accounts receivable allowance for doubtful accounts, percentage of completion revenue recognition method, the useful life of fixed assets and assumptions used in the fair value of stock-based compensation. Revenues and Cost Recognition Revenues from construction contracts are included in contract revenue in the condensed consolidated statements of operations and are recognized under the percentage-of-completion accounting method. The percent complete is measured by the cost incurred to date compared to the estimated total cost of each project. This method is used as management considers expended cost to be the best available measure of progress on these contracts, the majority of which are completed within one year, but may occasionally extend beyond one year. Inherent uncertainties in estimating costs make it at least reasonably possible that the estimates used will change within the near term and over the life of the contracts. Contract costs include all direct material and labor costs and those indirect costs related to contract performance and completion. Provisions for estimated losses on uncompleted contracts are made in the period in which such losses are determined. General and administrative costs are charged to expense as incurred. Changes in job performance, job conditions and estimated profitability, including those arising from contract penalty provisions and final contract settlements, may result in revisions to costs and income. Such revisions are recognized in the period in which they are determined. Costs and estimated earnings in excess of billings are comprised principally of revenue recognized on contracts (on the percentage-of-completion method) for which billings had not been presented to customers because the amounts were not billable under the contract terms at the balance sheet date. In accordance with the contract terms, any unbilled receivables at period end will be billed subsequently. Amounts are billed based on contractual terms. Billings in excess of costs and estimated earnings represent billings in excess of revenues recognized. Inventory Inventory is stated at the lower of cost (first-in, first out) or market and consists primarily of construction materials. Stock-Based Compensation The Company measures the cost of services received in exchange for an award of equity instruments based on the fair value of the award. For employees, the fair value of the award is measured on the grant date and for non-employees, the fair value of the award is generally re-measured on vesting dates and interim financial reporting dates until the service period is complete. The fair value amount is then recognized over the period during which services are required to be provided in exchange for the award, usually the vesting period. Awards granted to directors are treated on the same basis as awards granted to employees. Concentrations of Credit Risk Financial instruments and related items, which potentially subject the Company to concentrations of credit risk, consist primarily of cash and cash equivalents. The Company places its cash and temporary cash investments with credit quality institutions. At times, such amounts may be in excess of the FDIC insurance limit. Accounts Receivable and Allowance for Doubtful Accounts Accounts receivable are stated at the amount management expects to collect from outstanding balances. The Company generally does not require collateral to support customer receivables. The Company provides an allowance for doubtful accounts based upon a review of the outstanding accounts receivable, historical collection information and existing economic conditions. The Company determines if receivables are past due based on days outstanding, and amounts are written off when determined to be uncollectible by management. The maximum accounting loss from the credit risk associated with accounts receivable is the amount of the receivable recorded, which is the face amount of the receivable, net of the allowance for doubtful accounts. As of March 31, 2017, and December 31, 2016, the Company’s accounts receivable balance was $445,719 and $354,159, respectively, and the allowance for doubtful accounts is $0 in each period. Warranty Costs The Company generally provides a warranty on the products installed for up to 8 years with certain limitations and exclusions based upon the manufacturer’s product warranty. However, based upon historical warranty issues, the Company has established a warranty reserve. Fair Value of Financial Instruments Accounting Standards Codification subtopic 825-10, Financial Instruments (“ASC 825-10”) requires disclosure of the fair value of certain financial instruments. The carrying value of cash and cash equivalents, accounts payable and accrued liabilities, and short-term borrowings, as reflected in the balance sheets, approximate fair value because of the short-term maturity of these instruments. All other significant financial assets, financial liabilities and equity instruments of the Company are either recognized or disclosed in the financial statements together with other information relevant for making a reasonable assessment of future cash flows, interest rate risk and credit risk. Where practicable the fair values of financial assets and financial liabilities have been determined and disclosed; otherwise only available information pertinent to fair value has been disclosed. Beneficial Conversion Feature For conventional convertible debt where the rate of conversion is below market value, the Company records a “beneficial conversion feature” (“BCF”) and related debt discount. When the Company records a BCF the relative fair value of the BCF would be recorded as a debt discount against the face amount of the respective debt instrument. The debt discount attributable to the BCF is amortized over the period from issuance to the date that the debt matures. Derivative Instruments The Company evaluates its convertible debt, warrants or other contracts to determine if those contracts or embedded components of those contracts qualify as derivatives to be separately accounted for in accordance with ASC 815-15. The result of this accounting treatment is that the fair value of the embedded derivative is marked-to-market each balance sheet date and recorded as a liability. In the event that the fair value is recorded as a liability, the change in fair value is recorded in the statements of operations as other income or expense. Upon conversion or exercise of a derivative instrument, the instrument is marked to fair value at the conversion date and then that fair value is reclassified to equity. In circumstances where the embedded conversion option in a convertible instrument is required to be bifurcated and there are also other embedded derivative instruments in the convertible instrument that are required to be bifurcated, the bifurcated derivative instruments are accounted for as a single, compound derivative instrument. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period. Equity instruments that are initially classified as equity that become subject to reclassification are reclassified to liability at the fair value of the instrument on the reclassification date. Net Income (Loss) Per Common Share The Company computes basic net income (loss) per share by dividing net income (loss) per share available to common stockholders by the weighted average number of common shares outstanding for the period and excludes the effects of any potentially dilutive securities. Diluted earnings per share, if presented, would include the dilution that would occur upon the exercise or conversion of all potentially dilutive securities into common stock using the “treasury stock” and/or “if converted” methods as applicable. The computation of basic and diluted loss per share excludes potentially dilutive securities because their inclusion would be anti-dilutive. Anti-dilutive securities excluded from the computation of basic and diluted net loss per share for the three months ended March 31, 2017 and 2016, respectively, are as follows: March 31, 2017 2016 Warrants to purchase common stock 679,588 600,480 Options to purchase common stock 997,500 622,500 Unvested restricted common shares 75,000 100,000 Convertible Notes 2,593,934 670,136 Totals 4,346,022 1,993,116 Shares outstanding Shares outstanding include shares of unvested restricted stock. Unvested restricted stock included in reportable shares outstanding was 75,000 and 100,000 shares as of March 31, 2017 and 2016, respectively. Shares of unvested restricted stock are excluded from our calculation of basic weighted average shares outstanding, but their dilutive impact is added back in the calculation of diluted weighted average shares outstanding. Significant Customers The Company’s business focuses on securing a smaller number of high quality, highly profitable projects, which sometimes results in having a concentration of sales and accounts receivable among a few customers. This concentration is customary among the design and build industry for a company of our size. As we continue to grow and are awarded more projects, this concentration will continue to decrease. At March 31, 2017, the Company had one customer representing 98% of the total accounts receivable balance. At December 31, 2016, the Company had one customer representing 91% of the total accounts receivable balance. For the three months ended March 31, 2017, the Company had 2 customers that represented 78% of the total revenues and for the three months ended March 31, 2016, the Company had 3 customers that represented 71%, 12% and 11% of the total revenues. Reclassifications Certain items in the prior year financial statements have been reclassified to conform to the current year presentation. Recent Accounting Guidance Not Yet Adopted During May 2014, the FASB issued ASU No. 2014-09, “Revenue from Contracts with Customers” (“ASU 2014-09”), which requires entities to recognize revenue in a way that depicts the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled to in exchange for those goods or services. The new guidance also requires additional disclosure about the nature, amount, timing and uncertainty of revenue and cash flows arising from customer contracts, including significant judgments and changes in judgments and assets recognized from costs incurred to obtain or fulfill a contract. In July 2015, the FASB voted to delay the effective date of ASU 2014-09 by one year to the first quarter of 2018 to provide companies sufficient time to implement the standards. Early Adoption will be permitted, but not before the first quarter of 2017. Adoption can occur using one of two prescribed transition methods. The Company has completed its initial assessment of the new standard and is in the process of assessing its contracts with customers. The Company will continue to assess the impact through its implementation process. The adoption of ASU 2014-09 is not expected to have a material impact on our consolidated financial position, results of operations or cash flows. In February 2016, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") No. 2016-02, “Leases” (topic 842). The FASB issued this update to increase transparency and comparability among organizations by recognizing lease assets and lease liabilities on the balance sheet and disclosing key information about leasing arrangements. The updated guidance is effective for annual periods beginning after December 15, 2018, including interim periods within those fiscal years. Early adoption of the update is permitted. The Company is currently evaluating the impact of the new standard on our consolidated financial statements. In April 2016, the Financial Accounting Standards Board (‘FASB”) issued Accounting Standards Update (“ASU”) No. 2016-10, “Revenue from Contracts with Customers: Identifying Performance Obligations and Licensing” (topic 606). In March 2016, the Financial Accounting Standards Board (‘FASB”) issued Accounting Standards Update (“ASU”) No. 2016-08, “Revenue from Contracts with Customers: Principal versus Agent Considerations (Reporting Revenue Gross verses Net)” (topic 606). These amendments provide additional clarification and implementation guidance on the previously issued ASU 2014-09, “Revenue from Contracts with Customers”. The amendments in ASU 2016-10 provide clarifying guidance on materiality of performance obligations; evaluating distinct performance obligations; treatment of shipping and handling costs; and determining whether an entity's promise to grant a license provides a customer with either a right to use an entity's intellectual property or a right to access an entity's intellectual property. The amendments in ASU 2016-08 clarify how an entity should identify the specified good or service for the principal versus agent evaluation and how it should apply the control principle to certain types of arrangements. The adoption of ASU 2016-10 and ASU 2016-08 is to coincide with an entity's adoption of ASU 2014-09, which we intend to adopt for interim and annual reporting periods beginning after December 15, 2017. The Company is currently evaluating the impact of the new standard on our consolidated financial statements. In August 2016, the Financial Accounting Standards Board (‘FASB”) issued Accounting Standards Update (“ASU”) No. 2016-15, "Statement of Cash Flows - Classification of Certain Cash Receipts and Cash Payments." ASU No. 2016-15 addresses specific cash flow classification issues where there is currently diversity in practice including debt prepayment and proceeds from the settlement of insurance claims. ASU 2016-15 is effective for annual periods beginning after December 15, 2017, with early adoption permitted. The Company is currently evaluating the impact of the new standard on our consolidated financial statements. In November 2016, the FASB issued ASU No. 2016-18 “Statement of Cash Flows (Topic 230), Restricted Cash” which provides guidance on the presentation of restricted cash and restricted cash equivalents in the statements of cash flows. The new guidance requires restricted cash and restricted cash equivalents to be included within the cash and cash equivalents balances when reconciling the beginning-of-period and end-of-period amounts shown on the statements of cash flows. The ASU is effective for reporting periods beginning after December 15, 2017 with early adoption permitted. The Company is currently evaluating the impact of the new standard on our consolidated financial statements. There were no other new accounting pronouncements that were issued or became effective that management believes are expected to have, a material impact on our consolidated financial position, results of operations or cash flows.

Going Concern

Going Concern	3 Months Ended
	Mar. 31, 2017
Going Concern [Abstract]
GOING CONCERN	NOTE 3 – GOING CONCERN As reflected in the accompanying condensed consolidated financial statements, as of March 31, 2017 the Company had a working capital deficit of $4,059,544. Furthermore, the Company had a net loss of $534,636 for the three months ended March 31, 2017 and an accumulated deficit totaling $14,492,216. Management has concluded that, due to these conditions, there is substantial doubt about the Company’s ability to continue as a going concern through May 2018. We have evaluated the significance of these conditions in relation to our ability to meet our obligations. The ability of the Company to continue its operations as a going concern is dependent on Management's plans, which include the raising of capital through debt and/or equity markets with some additional funding from other traditional financing sources, including but not limited to term notes, until such time that funds provided by operations are sufficient to fund working capital requirements. The Company will require additional funding to finance the growth of its current and expected future operations as well as to achieve its strategic objectives. The Company believes its current available cash along with anticipated revenues may be insufficient to meet its cash needs for the near future. There can be no assurance that financing will be available in amounts or terms acceptable to the Company, if at all. The accompanying condensed consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. These financial statements do not include any adjustments relating to the recovery of the recorded assets or the classification of the liabilities that might be necessary should the Company be unable to continue as a going concern.

Costs and Estimated Earnings on

Costs and Estimated Earnings on Contracts in Process	3 Months Ended
	Mar. 31, 2017
Costs and Estimated Earnings on Contracts in Process [Abstract]
COSTS AND ESTIMATED EARNINGS ON CONTRACTS IN PROCESS	NOTE 4 – COSTS AND ESTIMATED EARNINGS ON CONTRACTS IN PROCESS Following is a summary of costs, billings, and estimated earnings on contracts in process as of March 31, 2017 and December 31, 2016: March 31, December 31, 2017 2016 Costs incurred on contracts in progress $ 7,306,161 $ 6,299,675 Estimated earnings (losses) (147,771 ) (320,450 ) 7,158,390 5,979,225 Less billings to date (7,461,880 ) (6,344,596 ) $ (303,490 ) $ (365,371 ) The above accounts are shown in the accompanying condensed consolidated balance sheet under these captions at March 31, 2017 and December 31, 2016: March 31, December 31, 2017 2016 Costs and estimated earnings in excess of billings $ 392,556 $ 75,624 Billings in excess of costs and estimated earnings (662,648 ) (374,916 ) Provision for estimated losses on uncompleted contracts (33,398 ) (66,079 ) $ (303,490 ) $ (365,371 ) Warranty Costs During the three months ended March 31, 2017 and March 31, 2016, the Company incurred costs of approximately $18,000 and $9,500, respectively. The Company has implemented policies and procedures to avoid these costs in the future. The Company generally provides a warranty on the products installed for up to 8 years with certain limitations and exclusions based upon the manufacturer’s product warranty. However, based upon historical warranty issues, the Company has established a warranty reserve, which is $30,000 as of March 31, 2017 and $50,000 as of December 31, 2016.

Debt

Debt	3 Months Ended
	Mar. 31, 2017
Debt [Abstract]
DEBT	NOTE 5 – DEBT Convertible Notes On May 7, 2015, the Company issued unsecured convertible promissory notes (each a “Note” and collectively the “Notes”) in an aggregate principal amount of $450,000 to three accredited investors (collectively the “Note Holders”) through a private placement. The notes pay interest equal to 9% of the principal amount of the notes, payable in one lump sum, and mature on February 1, 2016 unless the notes are converted into common stock if the Company undertakes a qualified offering of securities of at least $2,000,000 (the “Qualified Offering”). The principal of the notes is convertible into shares of common stock at a conversion price that is the lower of $1.00 per share or the price per share offered in a Qualified Offering. In order to induce the investors to invest in the notes, one of the Company’s shareholders assigned an aggregate of 45,000 shares of his common stock to such investors. The Company recorded a $45,000 debt discount relating to the 45,000 shares of common stock issued with an offsetting entry to additional paid in capital. The debt discount shall be amortized to interest expense over the life of the notes. As part of the transaction, we incurred placement agent fees of $22,500 and legal fees of $22,500 which were recorded as debt issue costs and shall be amortized over the life of the notes. The outstanding principal balance on the notes at March 31, 2017 and December 31, 2016 was $522,668. The notes matured on February 1, 2016. On March 31, 2016, the Note Holders entered into a letter agreement whereby, effective as of February 1, 2016, they waived any and all defaults that may or may not have occurred prior to the date thereof (the “First Waiver”). As consideration for the First Waiver, the Company issued the Note Holders an aggregate of 45,000 shares of the Company’s common stock. The principal amount on the Notes increased from $450,000 to $490,500 as the initial interest amount, $40,500 as of February 1, 2016, was added to the principal amount of the Notes. The maturity date of the Notes was extended to July 1, 2016 and the Notes shall pay interest as of February 1, 2016 at a rate of 9% per annum, payable in one lump sum on the maturity date. In addition, on any note conversion date from February 1, 2016 through July 1, 2016, the Notes are convertible into shares of the Company’s common stock at a conversion price of $1.00 per share. On any Note conversion after July 1, 2016, the Notes are convertible into shares of the Company’s common stock at a conversion price that is the lower of (i) $1.00 per share and (ii) the volume-weighted average price for the last five trading days preceding the conversion date. All remaining terms of the Notes remained the same. Subsequent to the First Waiver, the Notes matured on July 1, 2016. On September 7, 2016, one Note Holder entered into a letter agreement whereby, effective as of August 1, 2016, they waived any and all defaults that may or may not have occurred prior to the date thereof (the “Second Waiver”). As consideration for the Second Waiver, the Company issued the Note Holder an aggregate of 40,000 shares of the Company’s common stock and added $15,000 to the principal amount of the note. The principal amount on the Note increased from $218,000 to $242,810 as the accrued interest amount, $9,810 as of August 1, 2016 and the aforementioned $15,000 of consideration, was added to the principal amount of the Note. The maturity date of the Note was extended to January 1, 2017 and the Note shall pay interest as of August 1, 2016 at a rate of 15% per annum, payable in one lump sum on the maturity date. In addition, on any note conversion date from August 9, 2016 through January 1, 2017, the Note is convertible into shares of the Company’s common stock at a conversion price of $1.00 per share. On any Note conversion after January 1, 2017, the Note is convertible into shares of the Company’s common stock at a conversion price that is the lower of (i) $1.00 per share and (ii) the volume-weighted average price for the last five trading days preceding the conversion date. All remaining terms of the Note remained the same. On October 21, 2016, a second Note Holder entered into a letter agreement whereby, effective as of August 1, 2016, they waived any and all defaults that may or may not have occurred prior to the date thereof (the “Second Waiver”). As consideration for the Second Waiver, the Company issued the Note Holder an aggregate of 30,000 shares of the Company’s common stock. The principal amount on the Note increased from $163,500 to $170,858 as the accrued interest amount, $7,358 as of August 1, 2016, was added to the principal amount of the Note. The maturity date of the Note was extended to January 1, 2017 and the Note shall pay interest as of August 1, 2016 at a rate of 15% per annum, payable in one lump sum on the maturity date. In addition, on any note conversion date from August 9, 2016 through January 1, 2017, the Note is convertible into shares of the Company’s common stock at a conversion price of $1.00 per share. On any Note conversion after January 1, 2017, the Note is convertible into shares of the Company’s common stock at a conversion price that is the lower of (i) $1.00 per share and (ii) the volume-weighted average price for the last five trading days preceding the conversion date. All remaining terms of the Note remained the same. Glenn Tilley, a director of the Company, is the holder of $170,858 of principal of the aforementioned Notes. As of July 1, 2016, the Company was not compliant with the repayment terms of all of the Notes. As of January 1, 2017, the Company was not compliant with the repayment terms of all of the Notes but no defaults under the Note have been called by the Note Holders. As of March 31, 2017, and December 31, 2016, the outstanding principal balance on the Notes was $522,688. The Company is currently conducting good faith negotiations with the Note Holders to further extend the maturity date, however, there can be no assurance that a further extension will be granted. The Company is currently accruing interest on the Notes at the default interest rate of 15% per annum. First Waiver In accordance with ASC 470, since the present value of the cash flows under the new debt instrument was not at least ten percent different from the present value of the remaining cash flows under the terms of the original debt instrument, the Company accounted for the First Waiver as a debt modification. Accordingly, the Company recorded a debt discount of $49,500 in the consolidated balance sheet. The debt discount was amortized to interest expense over the life of the note. The Company assessed the conversion feature of the Note in default at the end of the reporting period and concluded that the conversion feature of the Note did not qualify as a derivative because the settlement terms indicate that the Note is indexed to the entity’s underlying stock. The Company will reassess the conversion feature of the Note for derivative treatment at the end of each subsequent reporting period. On February 22, 2016 (the “Effective Date”), the Company issued a convertible note in the principal aggregate amount of $170,000 to a private investor The Company used the proceeds of the February 2016 Note to pay off a debenture issued in favor of a private investor on August 19, 2015. The debenture was in the principal amount of $150,000 and as of the date of this filing the investor has been paid all principal and interest due in full satisfaction thereof. As additional consideration for issuing the February 2016 Note, on the Effective Date the Company issued to the investor 35,000 shares of the Company’s restricted common stock. The Company recorded a $30,637 debt discount relating to the 35,000 shares of common stock issued. The debt discount was amortized to interest expense over the life of the convertible note. The intrinsic value of the February 2016 Note, when issued, gave rise to a beneficial conversion feature which was recorded as a discount to the note of $67,637 and was amortized over the period from issuance to the date that the debt matured. The Company assessed the conversion feature of the February 2016 Note on the date of issuance, on the date of default and at the end of each subsequent reporting period through September 30, 2016 and concluded the conversion feature of the note did not qualify as a derivative because there was no market mechanism for net settlement and it was not readily convertible to cash. The Company reassessed the conversion feature of the note for derivative treatment on December 31, 2016. Due to the fact that this convertible note has an option to convert at a variable amount, they are subject to derivative liability treatment. The Company has applied ASC No. 815, due to the potential for settlement in a variable quantity of shares. The conversion feature has been measured at fair value using a Black Scholes model at period end. The conversion feature, when reassessed, gave rise to a derivative liability of $204,300. In accordance with ASC 815 the $204,300 was charged to paid in-capital due to the fact a beneficial conversion feature was recorded on the original issue date. Gains and losses in future reporting periods from the change in fair value of the derivative liability will be recognized on the statements of operations. For the three months ended March 31, 2017 the company recorded again on the change in fair value of $81,900. As of March 31, 2017, the derivative liability was $122,400. The outstanding principal balance on the February 2016 Note at March 31, 2017 and December 31, 2016 was $170,000. As of August 19, 2016, the Company was not compliant with the repayment terms of this note but no defaults under the note have been called by the note holder. The Company is currently conducting good faith negotiations with the note holder to further extend the maturity date, however, there can be no assurance that a further extension will be granted. Accrued interest on this note is $30,042 and $23,667 as of March 31, 2017 and December 31, 2016, respectively. Promissory Notes On September 15, 2015, the Company entered into a short-term loan agreement with an investor. The principal amount of the loan was $200,000. The first $100,000 of the loan was payable upon the Company raising $500,000 in a qualified offering (as defined therein). The remaining balance was payable upon the Company raising $1,000,000 in a qualified offering. The loan bears interest at a rate of 8%. As part of the transaction, we incurred placement agent fees of $10,000 which were recorded as debt issue costs and amortized over the life of the loan. On May 3, 2016, the Company paid $10,000 in note principal and $10,000 of accrued interest on the loan and the Company entered into a promissory note with the lender for the remaining principal amount of $190,000. Pursuant to the terms of the promissory note agreement, the note bears interest at a rate of 8% and requires the Company to make one monthly principal payment of $10,000, one monthly principal payment of $12,500, eleven monthly principal payments of $15,000 and one monthly principal payment of $2,500, all along with interest starting on June 1, 2016. The note matures on July 1, 2017 and is unsecured. The outstanding principal balance on the note at March 31, 2017 and December 31, 2016 was $37,500 and $82,500, respectively. On July 14, 2016, the Company closed a Credit Agreement (the “Credit Agreement”) by and among the Company,First Form, Inc. (the “Borrowers”) and Genlink Capital, LLC, as lender (“Genlink”). Pursuant to the Credit Agreement, Genlink agreed to loan the Company up to a maximum of $1 million for general operating expenses. An initial amount of $670,000 was funded by Genlink at the closing of the Credit Agreement. Any increase in the amount extended to the Borrowers shall be at the discretion of Genlink. The amounts borrowed pursuant to the Credit Agreement are evidenced by a Revolving Note (the “Revolving Note”) and the repayment of the Revolving Note is secured by a first position security interest in substantially all of the Company’s assets in favor of Genlink, as evidenced by a Security Agreement by and among the Borrowers and Genlink (the “Security Agreement”). The Revolving Note is due and payable, along with interest thereon, on December 20, 2017, and bears interest at the rate of 15% per annum, increasing to 19% upon the occurrence of an event of default. The Company incurred loan fees of $44,500 for entering into the Credit Agreement. The loan fees shall be amortized to interest expense over the life of the notes. The Company must pay a minimum of $75,000 in interest over the life of the loan. The principal balance on the note as of March 31, 2017 was $1,000,000. At March 31, 2017, there was $ 23,508 remaining to be amortized. The principal balance on the note as of the date of this filing was $1,000,000. On January 26, 2017, the Company entered into a finance agreement with IPFS Corporation (“IPFS”). Pursuant to the terms of the agreement, IPFS loaned the Company the principal amount of $54,139, which would accrue interest at 3.95% per annum, to partially fund the payment of the premium of the Company’s general liability insurance. The agreement requires the Company to make nine monthly payments of $6,115, including interest starting on February 27, 2017. As of March 31, 2017, the outstanding balance related to this finance agreement was $42,536. On December 28, 2016, the Company entered into a finance agreement with First Insurance Funding (“FIF”). Pursuant to the terms of the agreement, FIF loaned the Company the principal amount of $31,492, which would accrue interest at 4.05% per annum, to partially fund the payment of the premium of the Company’s directors and officers insurance. The agreement requires the Company to make ten monthly payments of $3,208, including interest starting on January 3, 2017. As of March 31, 2017, the outstanding balance related to this finance agreement was $31,493. Debt under promissory notes is as follows: March 31, 2017 December 31, 2016 Promissory notes payable $ 1,111,528 $ 1,082,500 Less: Current maturities (1,088,020 ) (1,052,410 ) Less: Debt issuance costs (23,508 ) (30,090 ) Promissory notes payable, net of Current maturities and debt issuance costs $ 0 $ 0 Future minimum principal payments under promissory notes are as follows: Year ending December 31: 2017 $ 1,111,528 2018 and thereafter - $ 1,111,528

Factor Agreement

Factor Agreement	3 Months Ended
	Mar. 31, 2017
Factor Agreement [Abstract]
FACTOR AGREEMENT	NOTE 6 – FACTOR AGREEMENT On March 28, 2016, the Company entered into an agreement with a financial services company (the “Factor”) for the purchase and sale of accounts receivables. The financial services company advances up to 80% of qualified customer invoices and holds the remaining 20% as a reserve until the customer pays the financial services company. The released reserves are returned to the Company, less applicable discount fees. The Company is initially charged 2.0% on the face value of each invoice purchased and 0.008% for every 30 days the invoice remains outstanding. Uncollectable customer invoices are charged back to the Company after 90 days. Advances from the Factor are collateralized by all accounts receivable of the Company. The agreement terminated during 2016.

Stockholders Equity (Deficit)

Stockholders Equity (Deficit)	3 Months Ended
	Mar. 31, 2017
Stockholders Equity (Deficit) [Abstract]
STOCKHOLDERS EQUITY (DEFICIT)	NOTE 7 – STOCKHOLDERS EQUITY (DEFICIT) Preferred Stock The Company has authorized 20,000,000 shares of preferred stock, with a par value of $0.00001 per share. As of March 31, 2017, and December 31, 2016, the Company has -0- shares of preferred stock issued and outstanding. Common Stock The Company has authorized 250,000,000 shares of common stock, with a par value of $0.00001 per share. As of March 31, 2017, and December 31, 2016, the Company has 17,116,583 and 17,074,470 shares of common stock issued and outstanding, respectively. Common stock issued for services During the three months ended March 31, 2017, 1,500 shares of common stock were granted to a certain employee with a fair value of $585. During the three months ended March 31, 2017, 40,613 shares of common stock valued at $15,339 were issued to various consultants for professional services provided to the Company. Sale of common stock During the three months ended March 31, 2017, the Company did not sell any shares of common stock to investors. 2016 Incentive Stock Option Plan On October 4, 2016, the Board approved the Sports Field 2016 Incentive Stock Option Plan (the “2016 Plan”). The Plan provides for the issuance of up to 2,500,000 shares of common stock of the Company through the grant of non-qualified options (the “Non-qualified Options”), incentive options (the “Incentive Options” and together with the Non-qualified Options, the “Options”) and restricted stock (the “Restricted Stock”) and unrestricted stock (the “Unrestricted Stock”) to directors, officers, consultants, attorneys, advisors and employees. The 2,500,000 shares available under the 2016 Plan represent approximately 15% of the Company’s issued and outstanding common stock as of October 4, 2016. The Board believes the 2,500,000 shares that may be awarded under the 2016 Plan should be sufficient to cover grants through at least the end of the fiscal year 2018. Stock options issued for services On January 4, 2016, the Company issued a board member 200,000 common stock options for services. These options expire on January 4, 2021. On November 3, 2016, the Company issued our CEO 175,000 common stock options for services. These options expire on November 3, 2021. On November 3, 2016, the Company issued Nexphase Global 175,000 common stock options for services. These options expire on November 3, 2021. On March 31, 2017, the Company issued our CEO 25,000 common stock options for services. These options expire on March 31, 2022. The Company uses the Black-Scholes option pricing model to determine the fair value of the options granted. In applying the Black-Scholes option pricing model to options granted, the Company used the following weighted average assumptions: For the Three months Ended March 31, 2017 For the Year Ending December 31, 2016 Risk free interest rate 1.50% 1.26-1.73 % Dividend yield 0.00 % 0.00 % Expected volatility 43% 40% - 45 % Expected life in years 2.5 2.5 - 5 % Forfeiture Rate 0.00% 0.00 % Since the Company has limited trading history, volatility was determined by averaging volatilities of comparable companies. The expected term of the option, taking into account both the contractual term of the option and the effects of employees’ expected exercise and post-vesting employment termination behavior: The expected life of options and similar instruments represents the period of time the option and/or warrant are expected to be outstanding. Pursuant to paragraph 718-10-S99-1, it may be appropriate to use the simplified method i.e., expected term = ((vesting term + original contractual term) / 2) The following is a summary of the Company’s stock option activity during the three months ended March 31, 2017: Number of Options Weighted Average Exercise Price Weighted Average Remaining Contractual Life Outstanding – December 31, 2016 972,500 1.23 4.00 Granted 25,000 1.75 Exercised Forfeited/Cancelled Outstanding - March 31, 2017 997,500 1.24 3.77 Exercisable - March 31, 2017 922,500 1.26 3.78 At March 31, 2017 and 2016, the total intrinsic value of options outstanding was $0 and $0, respectively. At March 31, 2017 and 2016, the total intrinsic value of options exercisable was $0 and $0, respectively. Stock-based compensation for stock options has been recorded in the condensed consolidated statements of operations and totaled $9,126 for the three months ended March 31, 2017, and $34,571 for the three months ended March 31, 2016, respectively. As of March 31, 2017, the remaining balance of unamortized expense is $6,294 and is expected to be amortized over a remaining period of six months. Stock Warrants The following is a summary of the Company’s stock warrant activity during the three months ended March 31, 2017: Number of Warrants Weighted Average Exercise Price Weighted Average Remaining Contractual Life Outstanding - January 1, 2017 679,588 1.03 2.66 Granted Exercised Forfeited/Cancelled Outstanding - March 31, 2017 679,588 1.03 2.41 Exercisable - March 31, 2017 679,588 1.03 2.41 At March 31, 2017 and 2016, the total intrinsic value of warrants outstanding and exercisable was $0 and $0, respectively.

Related Party Transactions

Related Party Transactions	3 Months Ended
	Mar. 31, 2017
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS	NOTE 7 – STOCKHOLDERS EQUITY (DEFICIT) Preferred Stock The Company has authorized 20,000,000 shares of preferred stock, with a par value of $0.00001 per share. As of March 31, 2017, and December 31, 2016, the Company has -0- shares of preferred stock issued and outstanding. Common Stock The Company has authorized 250,000,000 shares of common stock, with a par value of $0.00001 per share. As of March 31, 2017, and December 31, 2016, the Company has 17,116,583 and 17,074,470 shares of common stock issued and outstanding, respectively. Common stock issued for services During the three months ended March 31, 2017, 1,500 shares of common stock were granted to a certain employee with a fair value of $585. During the three months ended March 31, 2017, 40,613 shares of common stock valued at $15,339 were issued to various consultants for professional services provided to the Company. Sale of common stock During the three months ended March 31, 2017, the Company did not sell any shares of common stock to investors. 2016 Incentive Stock Option Plan On October 4, 2016, the Board approved the Sports Field 2016 Incentive Stock Option Plan (the “2016 Plan”). The Plan provides for the issuance of up to 2,500,000 shares of common stock of the Company through the grant of non-qualified options (the “Non-qualified Options”), incentive options (the “Incentive Options” and together with the Non-qualified Options, the “Options”) and restricted stock (the “Restricted Stock”) and unrestricted stock (the “Unrestricted Stock”) to directors, officers, consultants, attorneys, advisors and employees. The 2,500,000 shares available under the 2016 Plan represent approximately 15% of the Company’s issued and outstanding common stock as of October 4, 2016. The Board believes the 2,500,000 shares that may be awarded under the 2016 Plan should be sufficient to cover grants through at least the end of the fiscal year 2018. Stock options issued for services On January 4, 2016, the Company issued a board member 200,000 common stock options for services. These options expire on January 4, 2021. On November 3, 2016, the Company issued our CEO 175,000 common stock options for services. These options expire on November 3, 2021. On November 3, 2016, the Company issued Nexphase Global 175,000 common stock options for services. These options expire on November 3, 2021. On March 31, 2017, the Company issued our CEO 25,000 common stock options for services. These options expire on March 31, 2022. The Company uses the Black-Scholes option pricing model to determine the fair value of the options granted. In applying the Black-Scholes option pricing model to options granted, the Company used the following weighted average assumptions: For the Three months Ended March 31, 2017 For the Year Ending December 31, 2016 Risk free interest rate 1.50% 1.26-1.73 % Dividend yield 0.00 % 0.00 % Expected volatility 43% 40% - 45 % Expected life in years 2.5 2.5 - 5 % Forfeiture Rate 0.00% 0.00 % Since the Company has limited trading history, volatility was determined by averaging volatilities of comparable companies. The expected term of the option, taking into account both the contractual term of the option and the effects of employees’ expected exercise and post-vesting employment termination behavior: The expected life of options and similar instruments represents the period of time the option and/or warrant are expected to be outstanding. Pursuant to paragraph 718-10-S99-1, it may be appropriate to use the simplified method i.e., expected term = ((vesting term + original contractual term) / 2) The following is a summary of the Company’s stock option activity during the three months ended March 31, 2017: Number of Options Weighted Average Exercise Price Weighted Average Remaining Contractual Life Outstanding – December 31, 2016 972,500 1.23 4.00 Granted 25,000 1.75 Exercised Forfeited/Cancelled Outstanding - March 31, 2017 997,500 1.24 3.77 Exercisable - March 31, 2017 922,500 1.26 3.78 At March 31, 2017 and 2016, the total intrinsic value of options outstanding was $0 and $0, respectively. At March 31, 2017 and 2016, the total intrinsic value of options exercisable was $0 and $0, respectively. Stock-based compensation for stock options has been recorded in the condensed consolidated statements of operations and totaled $9,126 for the three months ended March 31, 2017, and $34,571 for the three months ended March 31, 2016, respectively. As of March 31, 2017, the remaining balance of unamortized expense is $6,294 and is expected to be amortized over a remaining period of six months. Stock Warrants The following is a summary of the Company’s stock warrant activity during the three months ended March 31, 2017: Number of Warrants Weighted Average Exercise Price Weighted Average Remaining Contractual Life Outstanding - January 1, 2017 679,588 1.03 2.66 Granted Exercised Forfeited/Cancelled Outstanding - March 31, 2017 679,588 1.03 2.41 Exercisable - March 31, 2017 679,588 1.03 2.41 At March 31, 2017 and 2016, the total intrinsic value of warrants outstanding and exercisable was $0 and $0, respectively.

Employee Separation

Employee Separation	3 Months Ended
	Mar. 31, 2017
Employee Separation [Abstract]
EMPLOYEE SEPARATION	NOTE 9 – EMPLOYEE SEPARATION On December 30, 2016, the Company entered into a mutual general release and settlement agreement (the "Settlement Agreement") with the former employee. As of March 31, 2017, and December 31, 2016 the Company had accrued a liability of $4,895 and $45,000, respectively, related to the Settlement Agreement which has been included in accounts payable and accrued expenses in the accompanying condensed consolidated Balance Sheet.

Commitments and Contingencies

Commitments and Contingencies	3 Months Ended
	Mar. 31, 2017
Commitments and Contingencies [Abstract]
COMMITMENTS AND CONTINGENCIES	NOTE 10 – COMMITMENTS AND CONTINGENCIES Sports Field Contractors LLC, a subsidiary of the Company, is a grantor under a commercial security agreement issued in favor of Illini Bank, as lender, by The AllSynthetic Group, Inc., as borrower, on November 26, 2012, in connection with a loan made by Illini Bank to The AllSynthetic Group, Inc. in the amount of $249,314 (the “Illini Loan”). Jeremy Strawn, a former officer of the Company, executed the Illini Loan on behalf of The AllSynthetic Group, Inc. in his capacity as such company’s President/CEO. The Illini Loan appears to have matured on November 26, 2013 and appears to currently be in default. The Illini Loan is collateralized by all of the assets of Sports Field Contractors LLC; however, because Sports Field Contractors LLC is an inactive subsidiary of the Company and had no assets, the Company believes that it does not have any financial exposure in connection with the Illini Loan. Services Agreements On August 12, 2015, the Company entered into a Services Agreement with Aranea Partners. Aranea Partners agreed to provide investor relations services to the Company for a period of 12 months. As compensation for the services, the Company issued 50,000 shares of the Company common stock on August 12, 2015. On August 12, 2016, the Company issued an additional 100,000 shares of the Company’s common stock as per the terms of the agreement. Unvested shares are revalued at the end of each reporting period until they vest and are expensed on a straight-line basis over the term of the agreement. The Company has recorded compensation expense relating to the agreement of $0 and $39,781 during the three months ended March 31, 2017 and 2016, respectively. On August 4, 2015, the Company entered into a Services Agreement with a consultant. The consultant agreed to provide investor relations services to the Company for a period of 12 months. As compensation for the services, the Company issued 62,500 shares of the Company common stock on August 16, 2015. The contract was terminated during the second quarter of 2016. Unvested shares are revalued at the end of each reporting period until they vest and are expensed on a straight-line basis over the term of the agreement. The Company has recorded compensation expense relating to the agreement of $0 and $32,633 during the three months ended March 31, 2017 and 2016, respectively. On February 19, 2016 (the “Effective Date”), the Company entered into a Services Agreement with a consultant. The consultant agreed to provide investor relations services to the Company for a period of 12 months. As compensation for the services, the Company shall pay the consultant $12,000 per month and is obligated to issue 62,500 shares of the Company common stock upon the 90-day anniversary of the Effective Date and on the 180-day, 270-day and 360-day anniversary of the Effective Date, if the agreement is renewed as outline in the terms of the service. The Company may terminate this agreement by providing 5 days advance written notice in the first 60 days of entering into this agreement and with 30 days advance written notice thereafter for the duration of the agreement. The contract was terminated during the fourth quarter of 2016. Unvested shares are revalued at the end of each reporting period until they vest and are expensed on a straight-line basis over the term of the agreement. The Company has recorded compensation expense relating to the equity portion of the agreement of $0 and $30,806 during the three months ended March 31, 2017 and March 31, 2016, respectively. On April 14, 2016 (the “Effective Date”), the Company entered into a Services Agreement with a consultant. The consultant agreed to provide financial and operational services to the Company. The agreement terminates on March 31, 2017. As compensation for the services, the Company shall pay the consultant $2,400 per month and is obligated to issue $1,000 in shares of the Company common stock to be issued quarterly in arrears based on a share price equal to the 30-day moving average share price. The Company may terminate this agreement by providing 21 days advance written notice for the duration of the agreement. On December 20, 2016, the Company entered into a Services Agreement with a consulting firm. The consulting firm agreed to provide investor relations services to the Company for a period of 6 months. As compensation for the services, the Company shall pay the consultant $6,500 per month and is obligated to issue 100,000 fully vested shares of the Company common stock to be issued within 30 days of execution of the agreement. The Company may terminate the agreement during the first 2 months of the term with or without reason by providing 7 days written notice. Consulting Agreements In March 2014, the Company reached an agreement with a consulting firm owned by the CEO of the Company to provide non-exclusive sales services. The consulting firm will receive between 3.5% and 5% commissions on sales referred to the Company. In addition, the consulting firm will receive a monthly fee of $6,000, 50,000 shares of common stock upon execution of the agreement, and 10,000 shares of common stock at the beginning of each three month period for the term of the agreement and any renewal periods thereafter. The agreement is for 18 months, and is renewable for successive 18 month terms. On December 10, 2014, the consulting agreement was amended. The monthly fee was increased to $10,000 per month retroactive to September 1, 2014 and 50,000 additional shares of common stock were issued. In addition, the consulting firm will be issued qualified stock options as follows: ● 100,000 stock options at an exercise price of $1.50 per share that vest on December 31, 2015 ● 100,000 stock options at an exercise price of $1.75 per share that vest on December 31, 2016 ● 100,000 stock options at an exercise price of $2.50 per share that vest on December 31, 2017 On November 3, 2016, the Board, pursuant to the consulting agreement, approved the issuance of (i) qualified options to purchase 100,000 shares of the Company’s Common Stock at a price of $1.50 vesting immediately with a grant date of November 3, 2016, (ii) qualified options to purchase 75,000 shares of the Company’s Common Stock at a price of $1.75 vesting on December 31, 2016, and (iii) qualified options to purchase 25,000 shares of the Company’s Common Stock at a price of $1.75 vesting on December 31, 2016, which options were to be have and have been issued in the first quarter of 2017. On March 14, 2016, the consulting agreement was further amended. The monthly fee was increased to $20,000 per month for a period of twelve months. At the end of the twelve month period the monthly payment reverts back to $10,000. In March 2014, the Company reached an agreement with a consulting firm to provide non-exclusive sales services. The consulting firm will receive up to 5% commissions on sales referred to the Company. The term of the agreement is for one year, and automatically renews for successive one year terms unless either party notifies the other, in writing, of its intention not to renew at least 60 days before the end of the initial term of this agreement or any renewal term. As compensation for the services, the Company shall pay the consultant $2,500 per month and is obligated to issue 50,000 shares of the Company common stock upon execution of the agreement and 10,000 shares of the Company common stock at the beginning of each three month period for the term of the agreement and any renewal periods thereafter. The Company may terminate this agreement by providing 5 days advance written notice in the first 60 days of entering into this agreement and with 30 days advance written notice thereafter for the duration of the agreement. In February 2015, the Company reached an agreement with a consulting firm to provide non-exclusive sales services with an effective date of February 10, 2015 (the “Effective Date”). The agreement expires on December 31, 2017 and automatically renews for successive one year terms unless either party notifies the other, in writing, of its intention not to renew at least 15 days before the end of the initial term of this agreement or any renewal term. As compensation for the services, the consultant will receive (i) 5% commissions on sales of products or services other than turf referred to the Company; (ii) commission based on square footage of turf sold to certain parties as outlined in the agreement; (iii) 100,000 shares of the Company common stock (the “Payment Shares”) upon execution of the agreement, which shall be subject to certain Clawback provisions. “Clawback” means (i) if this agreement is terminated by the Company prior to December 31, 2016, then 50,000 of the Payment Shares shall be forfeited, and cancelled by the Company; and (i) if this Agreement is terminated by the Company prior to December 31, 2017, then 25,000 of the Payment Shares shall be forfeited, and cancelled by the Company. No equity compensation will be owed in connection with any renewal term. Unvested shares are revalued at the end of each reporting period until they vest and are expensed on a straight-line basis over the term of the agreement. In February 2015, the Company reached an agreement with an individual to provide non-exclusive sales services with an effective date of January 1, 2015 (the “Effective Date”). The individual will receive up to 5% commissions on sales referred to the Company. The term of the agreement is for 18 months from the date of execution, and automatically renews for successive one year terms unless either party notifies the other, in writing, of its intention not to renew at least 90 days before the end of the initial term of this agreement or any renewal term. As compensation for the services, the Company shall pay the consultant $5,000 per month and is obligated to issue 25,000 shares of the Company common stock within 30 days of execution of the agreement, 25,000 shares of the Company common stock within 15 days of the date of execution and delivery of a certain synthetic turf contract and 20,000 shares of the Company common stock upon reaching certain sales milestones. In November 2015, the Company reached an agreement with an individual to provide non-exclusive sales services with an effective date of January 1, 2015 (the “Effective Date”). The term of the agreement is for 3 years from the date of execution, and automatically renews for successive one year terms unless either party notifies the other, in writing, of its intention not to renew at least 90 days before the end of the initial term of this agreement or any renewal term. As compensation for the services, the Company is obligated to issue 75,000 shares of the Company common stock (the “Payment Shares”) within 30 days of execution of the agreement, which shall be subject to certain Clawback provisions. “Clawback” means (i) if this agreement is terminated by the Company prior to September 30, 2016, then 50,000 of the Payment Shares shall be forfeited, and cancelled by the Company; and (i) if this Agreement is terminated by the Company prior to June 30, 2017, then 25,000 of the Payment Shares shall be forfeited, and cancelled by the Company. No equity compensation will be owed in connection with any renewal term. Unvested shares are revalued at the end of each reporting period until they vest and are expensed on a straight-line basis over the term of the agreement. In December 2015, the Company reached an agreement with an individual to provide non-exclusive sales services. The individual will receive up to 5% commissions on sales referred to the Company. The term of the agreement is for 18 months from the date of execution, and automatically renews for successive one year terms unless either party notifies the other, in writing, of its intention not to renew at least 90 days before the end of the initial term of this agreement or any renewal term. As compensation for the services, the Company is obligated to issue 25,000 shares of the Company common stock within 30 days of execution of the agreement, 125,000 shares of the Company common stock which shall vest at the rate of 25,000 shares per quarter, effective beginning as of the quarter ending March 31, 2016 and 20,000 shares of the Company common stock upon reaching certain sales milestones. No equity compensation will be owed in connection with any renewal term. Unvested shares are revalued at the end of each reporting period until they vest and are expensed on a straight-line basis over the term of the agreement. In March 2016, the Company reached an agreement with an individual to provide non-exclusive sales services with an effective date of March 15, 2016 (the “Effective Date”). The individual will receive up to 1% commissions on sales referred to the Company. The term of the agreement is for one year, and automatically renews for successive one year terms unless either party notifies the other, in writing, of its intention not to renew at least 60 days before the end of the initial term of this agreement or any renewal term. As compensation for the services, the Company is obligated to issue 4,000 shares of the Company common stock on the 15th day of each month for the first 4 months of this agreement; and (ii) 10,000 shares of the Company common stock for every $1 million in gross revenue earned by the Company attributable to projects sold by the individual. Unvested shares are revalued at the end of each reporting period until they vest and are expensed on a straight-line basis over the term of the agreement. In April 2016, the Company reached an agreement with an individual to provide non-exclusive sales services with an effective date of April 20, 2016 (the “Effective Date”). The individual will receive up to 4% commissions on sales referred to the Company. The term of the agreement is for one year, and automatically renews for successive one year terms. The Company may terminate this agreement by providing 60 days advance written notice for the duration of the agreement. As compensation for the services, the Company is obligated to issue 4,000 shares of the Company common stock on the 15th day of each month for the first 6 months of this agreement; and (ii) 10,000 shares of the Company common stock for every $1 million in gross revenue earned by the Company attributable to projects sold by the individual. Unvested shares are revalued at the end of each reporting period until they vest and are expensed on a straight-line basis over the term of the agreement. This agreement has been extended on similar terms. Employment Agreements In September 2014, Jeromy Olson entered into a 40-month employment agreement to serve in the capacity of CEO, with subsequent one year renewal periods (the “Olson Employment Agreement”). The CEO will receive a monthly salary of $10,000 that (1) will increase to $13,000 upon the Company achieving gross revenues of at least $10,000,000, as amended, and an operating margin of at least 15%, and (2) will increase to $16,000 per month upon the Company achieving gross revenues of at least $15,000,000 and an operating margin of at least 15%. The agreement provides for cash bonuses of 15% of the annual Adjusted EBITDA between $1 and $1,000,000, 10% of the annual Adjusted EBITDA between $1,000,001 and $2,000,000 and 5% of the annual Adjusted EBITDA greater than $2,000,000. For purposes of the agreement, Adjusted EBITDA is defined as earnings before interest, taxes, depreciation and amortization less share based payments, gains or losses on derivative instruments and other non-cash items approved by the Board of Directors. The CEO was issued 250,000 shares of common stock on the date of the agreement and received 250,000 shares of common stock on January 1, 2016. Lastly, the CEO will be issued qualified stock options as follows: ● 100,000 stock options at an exercise price of $1.50 per share that vest on December 31, 2015 ● 100,000 stock options at an exercise price of $1.75 per share that vest on December 31, 2016 ● 100,000 stock options at an exercise price of $2.50 per share that vest on December 31, 2017 On November 3, 2016, the Board, pursuant to the Olson Employment Agreement (as defined above), approved the issuance of (i) qualified options to purchase 100,000 shares of the Company’s Common Stock at a price of $1.50 vesting immediately with a grant date of November 3, 2016 and (ii) qualified options to purchase 75,000 shares of the Company’s Common Stock at a price of $1.75 vesting on December 31, 2016, and (iii) qualified options to purchase 25,000 shares of the Company’s Common Stock at a price of $1.75 vesting on December 31, 2016, which options were to be have and have been issued in the first quarter of 2017. Advisory Board Agreements On February 11, 2016, the Company entered into an advisory board agreement with John Brenkus, effective June 1, 2016 (the (“Effective Date”). The term of the agreement is for a period of 24 months commencing on the Effective Date. Pursuant to the agreement, Mr. Brenkus is to be issued 25,000 shares of the Company common stock at the beginning of each quarter starting on the Effective Date through the term of the agreement. Supply Agreement On December 2, 2015, IMG Academy LLC (“IMG”) and the Company entered into an Official Supplier Agreement (the “Agreement”). The term of the Agreement is January 1, 2016 through December 31, 2019 (the “Term”). Under the Agreement, The Company is to be the “Official Supplier” of IMG in connection with certain of the Company’s products and related services during the Term. Additionally, the Agreement provides the Company with certain promotional opportunities and supplier benefits including but not limited to (i) on-site signage and Company brand exposure (ii) the opportunity to install up to 4 test turf plots (the “Test Plots”) in order for the Company to conduct research on its turf products and the ability to use IMG athletes as participants in such testing (ii) opportunity to schedule site visits of test plots for potential Company customers and (iv) access to IMG’s personnel to include Head Coaches, Athletic Director and Administrators, subject to clearances and applicable rules of governing bodies such as NCAA. As consideration for its designation as IMG’s “Official Supplier” the Company must pay IMG three installments of $208,000 during the Term as specified in the Agreement. As of the three month period ended March 31, 2017 and March 31, 2016, the Company has recorded $ 39,126 and $39,126 of expense related to the agreement, respectively. Placement Agent and Finders Agreements The Company entered into a second exclusive Financial Advisory and Investment Banking Agreement with Spartan Capital Securities, LLC (“Spartan”) effective October 1, 2015 (the “2015 Spartan Advisory Agreement”). Pursuant to the 2015 Spartan Advisory Agreement, among other things Spartan will act as the Company’s exclusive financial advisor and provide investment banking services. Spartan is to be paid (i) a monthly fee of $10,000 for 4 months for the period commencing October 1, 2015 through January 1, 2016; and contingent upon Spartan successfully raising $2.0 million under the 2015 Spartan Advisory Agreement (ii) a monthly fee of $5,000 for 6 months for the period commencing February 1, 2016 through July 1, 2016; (iii) a monthly fee of $7,500 for 6 months for the period commencing August 1, 2016 through January 1, 2017; (vi) a monthly fee of $10,000 for 12 months for the period commencing February 1, 2017 through January 1, 2018; and (vi) a monthly fee of $13,700 for 12 months for the period commencing February 1, 2018 through January 1, 2019. The obligation to pay the monthly fee shall survive any termination of this agreement. The 2015 Spartan Advisory Agreement expires on January 1, 2019. As of March 31, 2017, and December 31, 2016, Spartan was owed fees of $76,250 and $17,500, respectively. Litigation The Company had been put on notice by Brock USA, LLC d/b/a Brock International LLC (“Brock”) of patent infringement relating to certain products acquired by the Company from NexxField, Inc. (“NexxField”), namely, NexxField’s NexxPad turf underlayment panels. In July 2016, Brock commenced a patent infringement lawsuit against NexxField alleging that NexxField’s NexxPad panels infringe certain patents owned by Brock. In February 2017, the Company was informed by NexxField that it had settled its dispute with Brock. The Company was never named as a defendant in Brock’s patent infringement action and believes this matter to be resolved with no adverse effects to its business. Operating Leases On April 1, 2014, the Company entered into a new lease agreement for its office space in Massachusetts. The lease commenced on that date and expires on March 31, 2017. The lease has minimum monthly payments of $2,115, $2,151 and $2,188 for year one, two and three, respectively. The Company was required to pay a security deposit to the lessor totaling $6,417. In October 2014, the Company vacated the office space and subsequently defaulted on the lease. No amounts are owed or expected to be owed on this lease. On October 2, 2016, the Company entered into a new lease agreement for its office space in Illinois. The lease commences on January 1, 2017 and expires on December 31, 2017. The lease has minimum monthly payments of $1,045. The lease automatically renews for periods of 12 months unless three months’ notice is provided by either the Company or the landlord. The Company was required to pay a security deposit to the lessor totaling $2,090. Rent expense was $3,135 and $3,135 for the three months ended March 31, 2017 and March 31, 2016, respectively.

Significant Accounting Polici16

Significant Accounting Policies (Policies)	3 Months Ended
	Mar. 31, 2017
Significant Accounting Policies [Abstract]
Principles of Consolidation	Principles of Consolidation The accompanying condensed consolidated financial statements include the accounts of Sports Field Holdings, Inc. and its wholly owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation.
Use of Estimates	Use of Estimates The preparation of condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenue and expenses during the periods. Actual results could differ from those estimates. The Company’s significant estimates and assumptions include the accounts receivable allowance for doubtful accounts, percentage of completion revenue recognition method, the useful life of fixed assets and assumptions used in the fair value of stock-based compensation.
Revenues and Cost Recognition	Revenues and Cost Recognition Revenues from construction contracts are included in contract revenue in the condensed consolidated statements of operations and are recognized under the percentage-of-completion accounting method. The percent complete is measured by the cost incurred to date compared to the estimated total cost of each project. This method is used as management considers expended cost to be the best available measure of progress on these contracts, the majority of which are completed within one year, but may occasionally extend beyond one year. Inherent uncertainties in estimating costs make it at least reasonably possible that the estimates used will change within the near term and over the life of the contracts. Contract costs include all direct material and labor costs and those indirect costs related to contract performance and completion. Provisions for estimated losses on uncompleted contracts are made in the period in which such losses are determined. General and administrative costs are charged to expense as incurred. Changes in job performance, job conditions and estimated profitability, including those arising from contract penalty provisions and final contract settlements, may result in revisions to costs and income. Such revisions are recognized in the period in which they are determined. Costs and estimated earnings in excess of billings are comprised principally of revenue recognized on contracts (on the percentage-of-completion method) for which billings had not been presented to customers because the amounts were not billable under the contract terms at the balance sheet date. In accordance with the contract terms, any unbilled receivables at period end will be billed subsequently. Amounts are billed based on contractual terms. Billings in excess of costs and estimated earnings represent billings in excess of revenues recognized.
Inventory	Inventory Inventory is stated at the lower of cost (first-in, first out) or market and consists primarily of construction materials.
Stock-Based Compensation	Stock-Based Compensation The Company measures the cost of services received in exchange for an award of equity instruments based on the fair value of the award. For employees, the fair value of the award is measured on the grant date and for non-employees, the fair value of the award is generally re-measured on vesting dates and interim financial reporting dates until the service period is complete. The fair value amount is then recognized over the period during which services are required to be provided in exchange for the award, usually the vesting period. Awards granted to directors are treated on the same basis as awards granted to employees.
Concentrations of Credit Risk	Concentrations of Credit Risk Financial instruments and related items, which potentially subject the Company to concentrations of credit risk, consist primarily of cash and cash equivalents. The Company places its cash and temporary cash investments with credit quality institutions. At times, such amounts may be in excess of the FDIC insurance limit.
Accounts Receivable and Allowance for Doubtful Accounts	Accounts Receivable and Allowance for Doubtful Accounts Accounts receivable are stated at the amount management expects to collect from outstanding balances. The Company generally does not require collateral to support customer receivables. The Company provides an allowance for doubtful accounts based upon a review of the outstanding accounts receivable, historical collection information and existing economic conditions. The Company determines if receivables are past due based on days outstanding, and amounts are written off when determined to be uncollectible by management. The maximum accounting loss from the credit risk associated with accounts receivable is the amount of the receivable recorded, which is the face amount of the receivable, net of the allowance for doubtful accounts. As of March 31, 2017, and December 31, 2016, the Company’s accounts receivable balance was $445,719 and $354,159, respectively, and the allowance for doubtful accounts is $0 in each period.
Warranty Costs	Warranty Costs The Company generally provides a warranty on the products installed for up to 8 years with certain limitations and exclusions based upon the manufacturer’s product warranty. However, based upon historical warranty issues, the Company has established a warranty reserve.
Fair Value of Financial Instruments	Fair Value of Financial Instruments Accounting Standards Codification subtopic 825-10, Financial Instruments (“ASC 825-10”) requires disclosure of the fair value of certain financial instruments. The carrying value of cash and cash equivalents, accounts payable and accrued liabilities, and short-term borrowings, as reflected in the balance sheets, approximate fair value because of the short-term maturity of these instruments. All other significant financial assets, financial liabilities and equity instruments of the Company are either recognized or disclosed in the financial statements together with other information relevant for making a reasonable assessment of future cash flows, interest rate risk and credit risk. Where practicable the fair values of financial assets and financial liabilities have been determined and disclosed; otherwise only available information pertinent to fair value has been disclosed.
Beneficial Conversion Feature	Beneficial Conversion Feature For conventional convertible debt where the rate of conversion is below market value, the Company records a “beneficial conversion feature” (“BCF”) and related debt discount. When the Company records a BCF the relative fair value of the BCF would be recorded as a debt discount against the face amount of the respective debt instrument. The debt discount attributable to the BCF is amortized over the period from issuance to the date that the debt matures.
Derivative Instruments	Derivative Instruments The Company evaluates its convertible debt, warrants or other contracts to determine if those contracts or embedded components of those contracts qualify as derivatives to be separately accounted for in accordance with ASC 815-15. The result of this accounting treatment is that the fair value of the embedded derivative is marked-to-market each balance sheet date and recorded as a liability. In the event that the fair value is recorded as a liability, the change in fair value is recorded in the statements of operations as other income or expense. Upon conversion or exercise of a derivative instrument, the instrument is marked to fair value at the conversion date and then that fair value is reclassified to equity. In circumstances where the embedded conversion option in a convertible instrument is required to be bifurcated and there are also other embedded derivative instruments in the convertible instrument that are required to be bifurcated, the bifurcated derivative instruments are accounted for as a single, compound derivative instrument. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period. Equity instruments that are initially classified as equity that become subject to reclassification are reclassified to liability at the fair value of the instrument on the reclassification date.
Net Income (Loss) Per Common Share	Net Income (Loss) Per Common Share The Company computes basic net income (loss) per share by dividing net income (loss) per share available to common stockholders by the weighted average number of common shares outstanding for the period and excludes the effects of any potentially dilutive securities. Diluted earnings per share, if presented, would include the dilution that would occur upon the exercise or conversion of all potentially dilutive securities into common stock using the “treasury stock” and/or “if converted” methods as applicable. The computation of basic and diluted loss per share excludes potentially dilutive securities because their inclusion would be anti-dilutive. Anti-dilutive securities excluded from the computation of basic and diluted net loss per share for the three months ended March 31, 2017 and 2016, respectively, are as follows: March 31, 2017 2016 Warrants to purchase common stock 679,588 600,480 Options to purchase common stock 997,500 622,500 Unvested restricted common shares 75,000 100,000 Convertible Notes 2,593,934 670,136 Totals 4,346,022 1,993,116
Shares outstanding	Shares outstanding Shares outstanding include shares of unvested restricted stock. Unvested restricted stock included in reportable shares outstanding was 75,000 and 100,000 shares as of March 31, 2017 and 2016, respectively. Shares of unvested restricted stock are excluded from our calculation of basic weighted average shares outstanding, but their dilutive impact is added back in the calculation of diluted weighted average shares outstanding.
Significant Customers	Significant Customers The Company’s business focuses on securing a smaller number of high quality, highly profitable projects, which sometimes results in having a concentration of sales and accounts receivable among a few customers. This concentration is customary among the design and build industry for a company of our size. As we continue to grow and are awarded more projects, this concentration will continue to decrease. At March 31, 2017, the Company had one customer representing 98% of the total accounts receivable balance. At December 31, 2016, the Company had one customer representing 91% of the total accounts receivable balance. For the three months ended March 31, 2017, the Company had 2 customers that represented 78% of the total revenues and for the three months ended March 31, 2016, the Company had 3 customers that represented 71%, 12% and 11% of the total revenues.
Reclassifications	Reclassifications Certain items in the prior year financial statements have been reclassified to conform to the current year presentation.
Recent Accounting Guidance Not Yet Adopted	Recent Accounting Guidance Not Yet Adopted During May 2014, the FASB issued ASU No. 2014-09, “Revenue from Contracts with Customers” (“ASU 2014-09”), which requires entities to recognize revenue in a way that depicts the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled to in exchange for those goods or services. The new guidance also requires additional disclosure about the nature, amount, timing and uncertainty of revenue and cash flows arising from customer contracts, including significant judgments and changes in judgments and assets recognized from costs incurred to obtain or fulfill a contract. In July 2015, the FASB voted to delay the effective date of ASU 2014-09 by one year to the first quarter of 2018 to provide companies sufficient time to implement the standards. Early Adoption will be permitted, but not before the first quarter of 2017. Adoption can occur using one of two prescribed transition methods. The Company has completed its initial assessment of the new standard and is in the process of assessing its contracts with customers. The Company will continue to assess the impact through its implementation process. The adoption of ASU 2014-09 is not expected to have a material impact on our consolidated financial position, results of operations or cash flows. In February 2016, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") No. 2016-02, “Leases” (topic 842). The FASB issued this update to increase transparency and comparability among organizations by recognizing lease assets and lease liabilities on the balance sheet and disclosing key information about leasing arrangements. The updated guidance is effective for annual periods beginning after December 15, 2018, including interim periods within those fiscal years. Early adoption of the update is permitted. The Company is currently evaluating the impact of the new standard on our consolidated financial statements. In April 2016, the Financial Accounting Standards Board (‘FASB”) issued Accounting Standards Update (“ASU”) No. 2016-10, “Revenue from Contracts with Customers: Identifying Performance Obligations and Licensing” (topic 606). In March 2016, the Financial Accounting Standards Board (‘FASB”) issued Accounting Standards Update (“ASU”) No. 2016-08, “Revenue from Contracts with Customers: Principal versus Agent Considerations (Reporting Revenue Gross verses Net)” (topic 606). These amendments provide additional clarification and implementation guidance on the previously issued ASU 2014-09, “Revenue from Contracts with Customers”. The amendments in ASU 2016-10 provide clarifying guidance on materiality of performance obligations; evaluating distinct performance obligations; treatment of shipping and handling costs; and determining whether an entity's promise to grant a license provides a customer with either a right to use an entity's intellectual property or a right to access an entity's intellectual property. The amendments in ASU 2016-08 clarify how an entity should identify the specified good or service for the principal versus agent evaluation and how it should apply the control principle to certain types of arrangements. The adoption of ASU 2016-10 and ASU 2016-08 is to coincide with an entity's adoption of ASU 2014-09, which we intend to adopt for interim and annual reporting periods beginning after December 15, 2017. The Company is currently evaluating the impact of the new standard on our consolidated financial statements. In August 2016, the Financial Accounting Standards Board (‘FASB”) issued Accounting Standards Update (“ASU”) No. 2016-15, "Statement of Cash Flows - Classification of Certain Cash Receipts and Cash Payments." ASU No. 2016-15 addresses specific cash flow classification issues where there is currently diversity in practice including debt prepayment and proceeds from the settlement of insurance claims. ASU 2016-15 is effective for annual periods beginning after December 15, 2017, with early adoption permitted. The Company is currently evaluating the impact of the new standard on our consolidated financial statements. In November 2016, the FASB issued ASU No. 2016-18 “Statement of Cash Flows (Topic 230), Restricted Cash” which provides guidance on the presentation of restricted cash and restricted cash equivalents in the statements of cash flows. The new guidance requires restricted cash and restricted cash equivalents to be included within the cash and cash equivalents balances when reconciling the beginning-of-period and end-of-period amounts shown on the statements of cash flows. The ASU is effective for reporting periods beginning after December 15, 2017 with early adoption permitted. The Company is currently evaluating the impact of the new standard on our consolidated financial statements. There were no other new accounting pronouncements that were issued or became effective that management believes are expected to have, a material impact on our consolidated financial position, results of operations or cash flows.

Significant Accounting Polici17

Significant Accounting Policies (Tables)	3 Months Ended
	Mar. 31, 2017
Significant Accounting Policies [Abstract]
Schedule of anti-dilutive securities excluded from computation of basic and diluted net loss per share	March 31, 2017 2016 Warrants to purchase common stock 679,588 600,480 Options to purchase common stock 997,500 622,500 Unvested restricted common shares 75,000 100,000 Convertible Notes 2,593,934 670,136 Totals 4,346,022 1,993,116

Costs and Estimated Earnings 18

Costs and Estimated Earnings on Contracts in Process (Tables)	3 Months Ended
	Mar. 31, 2017
Costs and Estimated Earnings on Contracts in Process [Abstract]
Summary of costs, billings, and estimated earnings on contracts in process	March 31, December 31, 2017 2016 Costs incurred on contracts in progress $ 7,306,161 $ 6,299,675 Estimated earnings (losses) (147,771 ) (320,450 ) 7,158,390 5,979,225 Less billings to date (7,461,880 ) (6,344,596 ) $ (303,490 ) $ (365,371 )
Schedule of costs and estimated earnings included in balance sheet	March 31, December 31, 2017 2016 Costs and estimated earnings in excess of billings $ 392,556 $ 75,624 Billings in excess of costs and estimated earnings (662,648 ) (374,916 ) Provision for estimated losses on uncompleted contracts (33,398 ) (66,079 ) $ (303,490 ) $ (365,371 )

Stockholders Equity (Deficit) (

Stockholders Equity (Deficit) (Tables)	3 Months Ended
	Mar. 31, 2017
Stockholders Equity (Deficit) [Abstract]
Schedule of Black-Scholes option pricing model	For the Three months Ended March 31, 2017 For the Year Ending December 31, 2016 Risk free interest rate 1.50% 1.26-1.73 % Dividend yield 0.00 % 0.00 % Expected volatility 43% 40% - 45 % Expected life in years 2.5 2.5 - 5 % Forfeiture Rate 0.00% 0.00 %
Schedule of stock option activity	Number of Options Weighted Average Exercise Price Weighted Average Remaining Contractual Life Outstanding – December 31, 2016 972,500 1.23 4.00 Granted 25,000 1.75 Exercised Forfeited/Cancelled Outstanding - March 31, 2017 997,500 1.24 3.77 Exercisable - March 31, 2017 922,500 1.26 3.78
Schedule of stock warrant activity	Number of Warrants Weighted Average Exercise Price Weighted Average Remaining Contractual Life Outstanding - January 1, 2017 679,588 1.03 2.66 Granted Exercised Forfeited/Cancelled Outstanding - March 31, 2017 679,588 1.03 2.41 Exercisable - March 31, 2017 679,588 1.03 2.41

Debt (Tables)

Debt (Tables)	3 Months Ended
	Mar. 31, 2017
Debt [Abstract]
Schedule of debt under promissory notes	March 31, 2017 December 31, 2016 Promissory notes payable $ 1,111,528 $ 1,082,500 Less: Current maturities (1,088,020 ) (1,052,410 ) Less: Debt issuance costs (23,508 ) (30,090 ) Promissory notes payable, net of Current maturities and debt issuance costs $ 0 $ 0
Schedule of future minimum principal payments under promissory notes	Year ending December 31: 2017 $ 1,111,528 2018 and thereafter - $ 1,111,528

Significant Accounting Polici21

Significant Accounting Policies (Details) - shares	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Totals	4,346,022	1,993,116
Warrants to purchase common stock [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Totals	679,588	600,480
Options to purchase common stock [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Totals	997,500	622,500
Unvested restricted common shares [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Totals	75,000	100,000
Convertible Notes [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Totals	2,593,934	670,136

Significant Accounting Polici22

Significant Accounting Policies (Details Textual)	3 Months Ended		12 Months Ended
	Mar. 31, 2017USD ($)Customersshares	Mar. 31, 2016Customersshares	Dec. 31, 2016USD ($)Customers
Significant Accounting Policies (Textual)
Accounts Receivable | $	$ 445,719		$ 354,159
Allowance for doubtful accounts | $	$ 0		$ 0
Warranty costs, description	The Company generally provides a warranty on the products installed for up to 8 years with certain limitations and exclusions based upon the manufacturer's product warranty.
Shares outstanding | shares	75,000	100,000
Accounts Receivable [Member] | Customer One [Member]
Significant Accounting Policies (Textual)
Concentration of credit risk percentage	98.00%		91.00%
Number of customers | Customers	1		1
Revenues [Member] | Customers [Member]
Significant Accounting Policies (Textual)
Concentration of credit risk percentage	78.00%
Number of customers | Customers	2	3
Revenues [Member] | Customer One [Member]
Significant Accounting Policies (Textual)
Concentration of credit risk percentage		71.00%
Revenues [Member] | Customer Two [Member]
Significant Accounting Policies (Textual)
Concentration of credit risk percentage		12.00%
Revenues [Member] | Customer Three [Member]
Significant Accounting Policies (Textual)
Concentration of credit risk percentage		11.00%

Going Concern (Details)

Going Concern (Details) - USD ($)	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016	Dec. 31, 2016
Going Concern (Textual)
Working capital deficit	$ 4,059,544
Incurred net losses	(534,636)	$ (1,127,774)
Accumulated deficit	$ (14,492,216)		$ (13,957,580)

Costs and Estimated Earnings 24

Costs and Estimated Earnings on Contracts in Process (Details) - USD ($)	Mar. 31, 2017	Dec. 31, 2016
Costs and Estimated Earnings on Contracts in Process [Abstract]
Costs incurred on contracts in progress	$ 7,306,161	$ 6,299,675
Estimated earnings (losses)	(147,771)	(320,450)
Costs and estimated earnings (losses) incurred on contracts in progress	7,158,390	5,979,225
Less billings to date	(7,461,880)	(6,344,596)
Cost in excess of billing on contracts in process, net	$ (303,490)	$ (365,371)

Costs and Estimated Earnings 25

Costs and Estimated Earnings on Contracts in Process (Details 1) - USD ($)	Mar. 31, 2017	Dec. 31, 2016
Costs and Estimated Earnings on Contracts in Process [Abstract]
Costs and estimated earnings in excess of billings	$ 392,556	$ 75,624
Billings in excess of costs and estimated earnings	(662,648)	(374,916)
Provision for estimated losses on uncompleted contracts	(33,398)	(66,079)
Cost in excess of billing on contracts in process, net	$ (303,490)	$ (365,371)

Costs and Estimated Earnings 26

Costs and Estimated Earnings on Contracts in Process (Details Textual) - USD ($)	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016	Dec. 31, 2016
Costs and Estimated Earnings on Contracts in Process (Textual)
Warranty costs, description	The Company generally provides a warranty on the products installed for up to 8 years with certain limitations and exclusions based upon the manufacturer's product warranty.
Warranty incurred costs	$ 18,000	$ 9,500
Warranty reserve	$ 30,000		$ 50,000

Debt (Details)

Debt (Details) - USD ($)	Mar. 31, 2017	Dec. 31, 2016
Debt [Abstract]
Promissory notes payable	$ 1,111,528	$ 1,082,500
Less: Current maturities	(1,088,020)	(1,052,410)
Less: Debt issuance costs	(23,508)	(30,090)
Promissory notes payable, net of Current maturities and debt issuance costs	$ 0	$ 0

Debt (Details 1)

Debt (Details 1)	Mar. 31, 2017USD ($)
Debt [Abstract]
2,017	$ 1,111,528
2018 and thereafter
Long term debt	$ 1,111,528

Debt (Details Textual)

Debt (Details Textual) - USD ($)

Oct. 21, 2016

Sep. 07, 2016

Aug. 01, 2016

Jul. 14, 2016

May 03, 2016

May 07, 2015

Dec. 20, 2017

Jan. 26, 2017

Dec. 28, 2016

Feb. 22, 2016

Sep. 15, 2015

Sep. 30, 2014

Mar. 31, 2017

Mar. 31, 2016

Dec. 31, 2016

Aug. 19, 2015

Debt (Textual)

Maximum general operating expenses

$ 751,861

$ 1,015,991

Aggregate shares of common stock

45,000

Common stock issued

250,000

Beneficial conversion feature

$ 67,637

Derivative liability

122,400

$ 204,300

Additional paid in capital

10,437,001

10,404,451

IPFS Corporation [Member]

Debt (Textual)

Aggregate principal amount

$ 54,139

Outstanding principal balance

42,536

Promissory note monthly payments

$ 6,115

Accrue interest rate, description

Accrue interest at 3.95% per annum.

Genlink Capital, LLC [Member]

Debt (Textual)

Aggregate principal amount

$ 670,000

First Insurance Funding [Member]

Debt (Textual)

Aggregate principal amount

$ 31,492

Outstanding principal balance

31,493

Promissory note monthly payments

$ 3,208

Accrue interest rate, description

Accrue interest at 4.05% per annum.

Investor [Member]

Debt (Textual)

Debt discount

$ 30,637

Common stock issued

35,000

Note holder [Member]

Debt (Textual)

Outstanding principal balance

$ 522,668

Note default interest rate

15.00%

Accrued interest

$ 30,042

23,667

Credit Agreement [Member]

Debt (Textual)

Aggregate principal amount

1,000,000

Amortized cost

23,508

Credit Agreement [Member] | Subsequent Event [Member]

Debt (Textual)

Note default interest rate

15.00%

Interest amount

$ 75,000

Loan fees

$ 44,500

Increase interest rate

19.00%

Convertible Notes [Member]

Debt (Textual)

Aggregate principal amount

$ 450,000

$ 170,000

$ 150,000

Outstanding principal balance

$ 522,688

522,688

Note default interest rate

9.00%

12.00%

15.00%

Maturity date

Feb. 1, 2016

Aug. 19, 2016

Debt discount

$ 45,000

Common stock, offering of securities

$ 2,000,000

Conversion price per share

$ 1

Aggregate shares of common stock

45,000

Placement agent fees

$ 22,500

Legal fees

$ 22,500

Maturity date, description

(i) from the Effective Date through the Maturity Date at $1.00 per share; and (ii) beginning one day after the Maturity Date, or notwithstanding the foregoing, at any time after the Company has registered shares of its common stock underlying the Note in a registration statement on Form S-1 or any other form applicable thereto, the lower of i) $1.00 per share and ii) 65% of the volume-weighted average price for the last twenty trading days preceding the conversion date.

Derivative liability

$ 122,400

Additional paid in capital

204,300

Change in fair value of derivative liability

81,900

Convertible Notes [Member] | One Note Holder [Member]

Debt (Textual)

Aggregate principal amount

$ 15,000

$ 15,000

Note default interest rate

15.00%

Accrued interest

$ 9,810

Maturity date

Jan. 1, 2017

Conversion price per share

$ 1

Debt conversion, description

On any Note conversion after January 1, 2017, the Note is convertible into shares of the Company's common stock at a conversion price that is the lower of (i) $1.00 per share and (ii) the volume-weighted average price for the last five trading days preceding the conversion date.

Common stock issued

40,000

Convertible Notes [Member] | One Note Holder [Member] | Maximum [Member]

Debt (Textual)

Aggregate principal amount

$ 242,810

Convertible Notes [Member] | One Note Holder [Member] | Minimum [Member]

Debt (Textual)

Aggregate principal amount

$ 218,000

Convertible Notes [Member] | Second Note Holder [Member]

Debt (Textual)

Aggregate principal amount

$ 170,858

Note default interest rate

15.00%

Accrued interest

$ 7,358

Maturity date

Jan. 1, 2017

Conversion price per share

$ 1

Debt conversion, description

On any Note conversion after January 1, 2017, the Note is convertible into shares of the Company's common stock at a conversion price that is the lower of (i) $1.00 per share and (ii) the volume-weighted average price for the last five trading days preceding the conversion date.

Common stock issued

30,000

Convertible Notes [Member] | Second Note Holder [Member] | Maximum [Member]

Debt (Textual)

Aggregate principal amount

$ 170,858

Convertible Notes [Member] | Second Note Holder [Member] | Minimum [Member]

Debt (Textual)

Aggregate principal amount

$ 163,500

First Waiver [Member]

Debt (Textual)

Outstanding principal balance

170,000

170,000

Note default interest rate

9.00%

Interest amount

$ 40,500

Maturity date

Jul. 1, 2016

Debt discount

49,500

Conversion price per share

$ 1

Aggregate shares of common stock

45,000

Maturity date, description

February 1, 2016 through July 1, 2016

Debt conversion, description

On any Note conversion after July 1, 2016, the Notes are convertible into shares of the Company's common stock at a conversion price that is the lower of (i) $1.00 per share and (ii) the volume-weighted average price for the last five trading days preceding the conversion date. All remaining terms of the Notes remained the same.

First Waiver [Member] | Maximum [Member]

Debt (Textual)

Outstanding principal balance

$ 490,500

First Waiver [Member] | Minimum [Member]

Debt (Textual)

Outstanding principal balance

$ 450,000

Promissory Notes [Member]

Debt (Textual)

Aggregate principal amount

$ 190,000

$ 200,000

Outstanding principal balance

$ 10,000

$ 37,500

$ 82,500

Note default interest rate

8.00%

8.00%

Accrued interest

$ 10,000

Promissory note monthly payments

$ 10,000

Maturity date

Jul. 1, 2017

Placement agent fees

$ 10,000

Debt instrument description

The first $100,000 of the loan was payable upon the Company raising $500,000 in a qualified offering (as defined therein). The remaining balance was payable upon the Company raising $1,000,000 in a qualified offering.

Promissory Notes [Member] | Genlink Capital, LLC [Member]

Debt (Textual)

Maximum general operating expenses

$ 1,000,000

Promissory Notes One [Member]

Debt (Textual)

Promissory note monthly payments

$ 12,500

Promissory Notes Two [Member]

Debt (Textual)

Promissory note monthly payments

15,000

Promissory Notes Three [Member]

Debt (Textual)

Promissory note monthly payments

$ 2,500

Factor Agreement (Details)

Factor Agreement (Details)	Mar. 28, 2016
Factor Agreement (Textual)
Financial services company advances, percentage	80.00%
Financial services company reserve, percentage	20.00%
Percentage charged on the face value of each invoice purchased	2.00%
Percentage for every 30 days the invoice remains outstanding	0.008%

Stockholders Equity (Deficit)31

Stockholders Equity (Deficit) (Details)	3 Months Ended	12 Months Ended
	Mar. 31, 2017	Dec. 31, 2016
Risk free interest rate	1.50%
Dividend yield	0.00%	0.00%
Expected volatility	43.00%
Expected life in years	2 years 6 months
Forfeiture Rate	0.00%	0.00%
Minimum [Member]
Risk free interest rate		1.26%
Expected volatility		40.00%
Expected life in years		2 years 6 months
Maximum [Member]
Risk free interest rate		1.73%
Expected volatility		445.00%
Expected life in years		5 years

Stockholders Equity (Deficit)32

Stockholders Equity (Deficit) (Details 1) - Stock Option [Member]	3 Months Ended
	Mar. 31, 2017$ / sharesshares
Class of Stock [Line Items]
Number of Options/Warrant, Outstanding | shares	972,500
Number of Warrants, Granted | shares	25,000
Number of Options, Exercised | shares
Number of Options, Forfeited/Cancelled | shares
Number of Options/Warrants, Outstanding | shares	997,500
Number of Options, Exercisable | shares	922,500
Weighted Average Exercise Price, Outstanding | $ / shares	$ 1.23
Weighted Average Exercise Price, Granted | $ / shares	1.75
Weighted Average Exercise Price, Exercised | $ / shares
Weighted Average Exercise Price, Forfeited/Cancelled | $ / shares
Weighted Average Exercise Price, Outstanding | $ / shares	1.24
Weighted Average Exercise Price, Exercisable | $ / shares	$ 1.26
Weighted Average Remaining Contractual Life, Outstanding	4 years
Weighted Average Remaining Contractual Life, Granted	0 years
Weighted Average Remaining Contractual Life, Exercised	0 years
Weighted Average Remaining Contractual Life, Forfeited/Cancelled	0 years
Weighted Average Remaining Contractual Life, Outstanding	3 years 9 months 7 days
Weighted Average Remaining Contractual Life, Exercisable	3 years 9 months 11 days

Stockholders Equity (Deficit)33

Stockholders Equity (Deficit) (Details 2) - Warrant [Member]	3 Months Ended
	Mar. 31, 2017$ / sharesshares
Class of Stock [Line Items]
Number of Options/Warrant, Outstanding | shares	679,588
Number of Warrants, Granted | shares
Number of Warrants, Exercised | shares
Number of Warrants, Forfeited/Cancelled | shares
Number of Warrants, Exercisable | shares	679,588
Number of Options/Warrants, Outstanding | shares	679,588
Weighted Average Exercise Price, Outstanding | $ / shares	$ 1.03
Weighted Average Exercise Price, Granted | $ / shares
Weighted Average Exercise Price, Exercised | $ / shares
Weighted Average Exercise Price, Forfeited/Cancelled | $ / shares
Weighted Average Exercise Price, Outstanding | $ / shares	1.03
Weighted Average Exercise Price, Exercisable | $ / shares	$ 1.03
Weighted Average Remaining Contractual Life, Outstanding	2 years 7 months 28 days
Weighted Average Remaining Contractual Life, Granted	0 years
Weighted Average Remaining Contractual Life, Exercised	0 years
Weighted Average Remaining Contractual Life, Forfeited/Cancelled	0 years
Weighted Average Remaining Contractual Life, Outstanding	2 years 4 months 28 days
Weighted Average Remaining Contractual Life, Exercisable	2 years 4 months 28 days

Stockholders Equity (Deficit)34

Stockholders Equity (Deficit) (Details Textual) - USD ($)	Nov. 03, 2016	Oct. 04, 2016	Jan. 04, 2016	Mar. 31, 2017	Mar. 31, 2016	Dec. 31, 2016
Stockholders Equity (Deficit) (Textual)
Preferred stock, shares authorized				20,000,000		20,000,000
Preferred stock, shares issued
Preferred stock, shares outstanding
Preferred stock, par value				$ 0.00001		$ 0.00001
Common stock, shares authorized				250,000,000		250,000,000
Common stock, par value				$ 0.00001		$ 0.00001
Common stock, shares issued				17,141,583		17,074,470
Common stock, shares outstanding				17,141,583		17,074,470
Employees [Member]
Stockholders Equity (Deficit) (Textual)
Common stock issued for services, shares				1,500
Common stock issued for services, value				$ 585
Consultants [Member]
Stockholders Equity (Deficit) (Textual)
Common stock issued for services, shares				40,613
Common stock issued for services, value				$ 15,339
2016 Incentive Stock Option Plan [Member]
Stockholders Equity (Deficit) (Textual)
Issuance of common stock shares		2,500,000
Description of options		The 2,500,000 shares available under the 2016 Plan represent approximately 15% of the Company's issued and outstanding common stock as of October 4, 2016. The Board believes the 2,500,000 shares that may be awarded under the 2016 Plan should be sufficient to cover grants through at least the end of the fiscal year 2018.
Intrinsic value of options outstanding				0	$ 0
Intrinsic value of options exercisable				0	0
Intrinsic value of warrants outstanding and exercisable				$ 0	0
Weighted average assumptions				$ 0
Stock-based compensation				$ 9,126	$ 34,571
Remaining balance of unamortized expense				$ 6,294
Amortized over remaining period				6 months
2016 Incentive Stock Option Plan [Member] | Board member [Member]
Stockholders Equity (Deficit) (Textual)
Stock options issued for services, shares			200,000
Stock option expire date			Jan. 4, 2021
2016 Incentive Stock Option Plan [Member] | CEO [Member]
Stockholders Equity (Deficit) (Textual)
Stock options issued for services, shares	175,000			25,000
Stock option expire date	Nov. 3, 2021			Mar. 31, 2022
2016 Incentive Stock Option Plan [Member] | Nexphase Global [Member]
Stockholders Equity (Deficit) (Textual)
Stock options issued for services, shares	175,000
Stock option expire date	Nov. 3, 2021

Related Party Transactions (Det

Related Party Transactions (Details) - USD ($)	1 Months Ended	3 Months Ended
	Sep. 30, 2014	Mar. 31, 2017	Mar. 31, 2016
Related Party Transactions (Textual)
Common stock shares issued	250,000
Glenn Tilley [Member]
Related Party Transactions (Textual)
Common stock shares issued			15,000
Nexphase Global [Member] | Jeromy Olson, Chief Executive Officer [Member]
Related Party Transactions (Textual)
Percentage of owns in sales management and consulting firm		50.00%
Consulting expenses		$ 93,900	$ 61,000
Common stock shares issued		10,000	10,000
Common stock shares, value		$ 3,900	$ 11,000

Employee Separation (Details)

Employee Separation (Details) - USD ($)	Mar. 31, 2017	Dec. 31, 2016
Employee Separation (Textual)
Accounts payable and accrued expenses	$ 4,895	$ 45,000

Commitments and Contingencies (

Commitments and Contingencies (Details) - USD ($)

Nov. 03, 2016

Oct. 02, 2016

Aug. 12, 2016

Apr. 14, 2016

Apr. 14, 2016

Mar. 14, 2016

Feb. 11, 2016

Dec. 02, 2015

Aug. 12, 2015

Aug. 04, 2015

Dec. 10, 2014

Apr. 01, 2014

Dec. 20, 2016

Apr. 30, 2016

Mar. 31, 2016

Feb. 19, 2016

Dec. 31, 2015

Nov. 30, 2015

Feb. 28, 2015

Sep. 30, 2014

Mar. 31, 2014

Mar. 31, 2017

Mar. 31, 2016

Dec. 31, 2016

Commitments and Contingencies (Textual)

Compensation expense

$ 0

$ 30,806

Loan from Illini

249,314

New shares issued during the period, shares

250,000

Accounts payable and accrued expenses

$ 4,895

$ 45,000

Number of shares of common Stock

10.00%

Operating leases rent expense

$ 3,135

3,135

Warrant [Member] | 2015 Financing [Member]

Commitments and Contingencies (Textual)

Number of shares of common Stock

10.00%

Term of warrants

5 years

Operating Leases [Member]

Commitments and Contingencies (Textual)

Lease expiration date

Dec. 31, 2017

Mar. 31, 2017

Monthly lease payments

$ 1,045

Operating lease description.

On October 2, 2016, the Company entered into a new lease agreement for its office space in Illinois. The lease commences on January 1, 2017 and expires on December 31, 2017. The lease has minimum monthly payments of $1,045. The lease automatically renews for periods of 12 months unless three months notice is provided by either the Company or the landlord. The Company was required to pay a security deposit to the lessor totaling $2,090.

Vesting period

1 year

Monthly lease payments year one

$ 2,115

Monthly lease payments year two

2,151

Monthly lease payments year three

2,188

Security deposit

$ 2,090

$ 6,417

Services Agreements [Member]

Commitments and Contingencies (Textual)

Description of agreement

Aranea Partners agreed to provide investor relations services to the Company for a period of 12 months.

Compensation expense

$ 0

39,781

Issuance of common stock for services

100,000

50,000

Services Agreements [Member] | Consulting Firm [Member]

Commitments and Contingencies (Textual)

Agreement term

6 months

Issuance of common stock for services

100,000

Compensation for the services

$ 6,500

Contract termination, description

The Company may terminate the agreement during the first 2 months of the term with or without reason by providing 7 days written notice.

Vesting period

30 days

Services Agreements [Member] | Consultant [Member]

Commitments and Contingencies (Textual)

Description of agreement

The consultant agreed to provide investor relations services to the Company for a period of 12 months.

On February 19, 2016 (the "Effective Date"), the Company entered into a Services Agreement with a consultant. The consultant agreed to provide investor relations services to the Company for a period of 12 months. As compensation for the services, the Company shall pay the consultant $12,000 per month and is obligated to issue 62,500 shares of the Company common stock upon the 90-day anniversary of the Effective Date and on the 180-day, 270-day and 360-day anniversary of the Effective Date, if the agreement is renewed as outline in the terms of the service. The Company may terminate this agreement by providing 5 days advance written notice in the first 60 days of entering into this agreement and with 30 days advance written notice thereafter for the duration of the agreement. The contract was terminated during the fourth quarter of 2016.

Compensation expense

$ 0

$ 32,633

Common stock issued as compensation for services

62,500

Services Agreements [Member] | Consultant One [Member]

Commitments and Contingencies (Textual)

Description of agreement

The Effective Date and on the 180-day, 270-day and 360-day anniversary of the Effective Date, if the agreement is renewed as outline in the terms of the service.

Agreement term

12 months

Issuance of common stock for services

62,500

Compensation for the services

$ 12,000

Contract termination, description

The contract was terminated during the fourth quarter of 2016.

Services Agreements [Member] | Consultant Two [Member]

Commitments and Contingencies (Textual)

Description of agreement

The agreement terminates on March 31, 2017.

Compensation for the services

$ 2,400

Contract termination, description

The Company may terminate this agreement by providing 21 days advance written notice for the duration of the agreement.

New shares issued during period, value

$ 1,000

Consulting Agreements [Member]

Commitments and Contingencies (Textual)

Agreement term

18 months

Monthly lease payments

$ 10,000

Monthly fee

$ 20,000

$ 10,000

$ 6,000

Additional shares of common stock obligated to issue

50,000

Shares received upon agreement execution

50,000

New shares issued during the period, shares

50,000

10,000

Vesting date of options

Nov. 3, 2016

Dec. 31, 2016

Dec. 31, 2016

Options issued to purchase common shares

100,000

25,000

75,000

Exercise price of an option

$ 1.50

$ 1.75

$ 1.75

Consulting Agreements [Member] | Exercise price of $1.50 [Member]

Commitments and Contingencies (Textual)

Vesting date of options

Dec. 31, 2015

Exercise price of an option

$ 1.50

Number of stock options issued or issuable

100,000

Consulting Agreements [Member] | Exercise price of $1.75 [Member]

Commitments and Contingencies (Textual)

Vesting date of options

Dec. 31, 2016

Exercise price of an option

$ 1.75

Number of stock options issued or issuable

100,000

Consulting Agreements [Member] | Exercise price of $2.50 [Member]

Commitments and Contingencies (Textual)

Vesting date of options

Dec. 31, 2017

Exercise price of an option

$ 2.50

Number of stock options issued or issuable

100,000

Consulting Agreements [Member] | Minimum [Member]

Commitments and Contingencies (Textual)

Percentage of commissions on sales

3.50%

Consulting Agreements [Member] | Maximum [Member]

Commitments and Contingencies (Textual)

Percentage of commissions on sales

5.00%

Consulting Agreements One [Member]

Commitments and Contingencies (Textual)

Description of agreement

The Company may terminate this agreement by providing 5 days advance written notice in the first 60 days of entering into this agreement and with 30 days advance written notice thereafter for the duration of the agreement.

Agreement term

1 year

Monthly fee

$ 2,500

Percentage of commissions on sales

5.00%

Shares received upon agreement execution

10,000

New shares issued during the period, shares

50,000

Consulting Agreements Two [Member]

Commitments and Contingencies (Textual)

Description of agreement

(i) if this agreement is terminated by the Company prior to December 31, 2016, then 50,000 of the Payment Shares shall be forfeited, and cancelled by the Company; and (i) if this Agreement is terminated by the Company prior to December 31, 2017, then 25,000 of the Payment Shares shall be forfeited, and cancelled by the Company.

Agreement term

1 year

Contract termination, description

The agreement expires on December 31, 2017 and automatically renews for successive one year terms.

Percentage of commissions on sales

5.00%

Shares received upon agreement execution

100,000

Consulting Agreements Two [Member] | Clawback [Member]

Commitments and Contingencies (Textual)

Payment shares forfeited, and cancelled

50,000

Consulting Agreements Two [Member] | Clawback One [Member]

Commitments and Contingencies (Textual)

Payment shares forfeited, and cancelled

25,000

Consulting Agreements Three [Member]

Commitments and Contingencies (Textual)

Description of agreement

In February 2015, the Company reached an agreement with an individual to provide non-exclusive sales services with an effective date of January 1, 2015 (the "Effective Date"). The individual will receive up to 5% commissions on sales referred to the Company. The term of the agreement is for 18 months from the date of execution, and automatically renews for successive one year terms unless either party notifies the other, in writing, of its intention not to renew at least 90 days before the end of the initial term of this agreement or any renewal term.

Agreement term

18 months

Issuance of common stock for services

25,000

Monthly fee

$ 5,000

Percentage of commissions on sales

5.00%

Shares received upon agreement execution

25,000

New shares issued during the period, shares

20,000

Consulting Agreements Three [Member] | 30 days of execution [Member]

Commitments and Contingencies (Textual)

Shares received upon agreement execution

25,000

Consulting Agreements Three [Member] | 15 days of execution [Member]

Commitments and Contingencies (Textual)

Shares received upon agreement execution

25,000

Consulting Agreements Four [Member]

Commitments and Contingencies (Textual)

Description of agreement

In November 2015, the Company reached an agreement with an individual to provide non-exclusive sales services with an effective date of January 1, 2015 (the "Effective Date"). The term of the agreement is for 3 years from the date of execution, and automatically renews for successive one year terms unless either party notifies the other, in writing, of its intention not to renew at least 90 days before the end of the initial term of this agreement or any renewal term.

Agreement term

3 years

Consulting Agreements Four [Member] | Clawback [Member]

Commitments and Contingencies (Textual)

Shares received upon agreement execution

75,000

Payment shares forfeited, and cancelled

50,000

Consulting Agreements Four [Member] | Clawback One [Member]

Commitments and Contingencies (Textual)

Payment shares forfeited, and cancelled

25,000

Consulting Agreements Five [Member]

Commitments and Contingencies (Textual)

Description of agreement

In December 2015, the Company reached an agreement with an individual to provide non-exclusive sales services. The individual will receive up to 5% commissions on sales referred to the Company. The term of the agreement is for 18 months from the date of execution, and automatically renews for successive one year terms unless either party notifies the other, in writing, of its intention not to renew at least 90 days before the end of the initial term of this agreement or any renewal term.

Agreement term

18 months

Percentage of commissions on sales

5.00%

Shares received upon agreement execution

25,000

New shares issued during the period, shares

125,000

Number of stock options issued or issuable

20,000

25,000

20,000

Consulting Agreements Six [Member]

Commitments and Contingencies (Textual)

Description of agreement

In March 2016, the Company reached an agreement with an individual to provide non-exclusive sales services with an effective date of March 15, 2016 (the "Effective Date"). The individual will receive up to 1% commissions on sales referred to the Company. The term of the agreement is for one year, and automatically renews for successive one year terms unless either party notifies the other, in writing, of its intention not to renew at least 60 days before the end of the initial term of this agreement or any renewal term.

Agreement term

1 year

Percentage of commissions on sales

1.00%

Shares received upon agreement execution

4,000

New shares issued during the period, shares

10,000

Increase of gross revenues

$ 1,000,000

Consulting Agreements Seven [Member]

Commitments and Contingencies (Textual)

Description of agreement

In April 2016, the Company reached an agreement with an individual to provide non-exclusive sales services with an effective date of April 20, 2016 (the "Effective Date"). The individual will receive up to 4% commissions on sales referred to the Company. The term of the agreement is for one year, and automatically renews for successive one year terms. The Company may terminate this agreement by providing 60 days advance written notice for the duration of the agreement.

Agreement term

1 year

Percentage of commissions on sales

4.00%

Shares received upon agreement execution

4,000

New shares issued during the period, shares

10,000

Increase of gross revenues

$ 1,000,000

Consulting Agreements Eight [Member]

Commitments and Contingencies (Textual)

Description of agreement

On April 14, 2016 (the "Effective Date"), the Company entered into a Services Agreement with a consultant. The consultant agreed to provide financial and operational services to the Company. The agreement terminates on March 31, 2017.

Employment Agreements [Member]

Commitments and Contingencies (Textual)

Description of agreement

In September 2014, Jeromy Olson entered into a 40 month employment agreement to serve in the capacity of CEO, with subsequent one year renewal periods (the "Olson Employment Agreement"). The CEO will receive a monthly salary of $10,000 that (1) will increase to $13,000 upon the Company achieving gross revenues of at least $10,000,000, as amended, and an operating margin of at least 15%, and (2) will increase to $16,000 per month upon the Company achieving gross revenues of at least $15,000,000 and an operating margin of at least 15%. The agreement provides for cash bonuses of 15% of the annual Adjusted EBITDA between $1 and $1,000,000, 10% of the annual Adjusted EBITDA between $1,000,001 and $2,000,000 and 5% of the annual Adjusted EBITDA greater than $2,000,000. For purposes of the agreement, Adjusted EBITDA is defined as earnings before interest, taxes, depreciation and amortization less share based payments, gains or losses on derivative instruments and other non-cash items approved by the Board of Directors. The CEO was issued 250,000 shares of common stock on the date of the agreement and received 250,000 shares of common stock on January 1, 2016.

New shares issued during the period, shares

100,000

Vesting date of options

Nov. 3, 2016

Increase of gross revenues

$ 13,000

Stock price per share

$ 1.50

Employment Agreements [Member] | CEO [Member]

Commitments and Contingencies (Textual)

Agreement term

40 months

New shares issued during the period, shares

250,000

Increase of gross revenues

$ 16,000

Operating margin rate

15.00%

Employment Agreements [Member] | CEO [Member] | 5% annual Adjusted EBITDA [Member]

Commitments and Contingencies (Textual)

EBITDA

$ 2,000,000

Employment Agreements [Member] | CEO [Member] | Exercise price of $1.50 [Member]

Commitments and Contingencies (Textual)

Vesting date of options

Dec. 31, 2015

Exercise price of an option

$ 1.50

Number of stock options issued or issuable

100,000

Employment Agreements [Member] | CEO [Member] | Exercise price of $1.75 [Member]

Commitments and Contingencies (Textual)

Vesting date of options

Dec. 31, 2016

Exercise price of an option

$ 1.75

Number of stock options issued or issuable

100,000

Employment Agreements [Member] | CEO [Member] | Exercise price of $2.50 [Member]

Commitments and Contingencies (Textual)

Vesting date of options

Dec. 31, 2017

Exercise price of an option

$ 2.50

Number of stock options issued or issuable

100,000

Employment Agreements [Member] | CEO [Member] | Minimum [Member]

Commitments and Contingencies (Textual)

Increase of gross revenues

$ 10,000,000

Officer salary per month

10,000

Employment Agreements [Member] | CEO [Member] | Minimum [Member] | 15% annual Adjusted EBITDA [Member]

Commitments and Contingencies (Textual)

EBITDA

1

Employment Agreements [Member] | CEO [Member] | Minimum [Member] | 10% annual Adjusted EBITDA [Member]

Commitments and Contingencies (Textual)

EBITDA

1,000,001

Employment Agreements [Member] | CEO [Member] | Maximum [Member]

Commitments and Contingencies (Textual)

Increase of gross revenues

15,000,000

Officer salary per month

13,000

Employment Agreements [Member] | CEO [Member] | Maximum [Member] | 15% annual Adjusted EBITDA [Member]

Commitments and Contingencies (Textual)

EBITDA

1,000,000

Employment Agreements [Member] | CEO [Member] | Maximum [Member] | 10% annual Adjusted EBITDA [Member]

Commitments and Contingencies (Textual)

EBITDA

$ 2,000,000

Employment Agreements One [Member]

Commitments and Contingencies (Textual)

New shares issued during the period, shares

75,000

Vesting date of options

Dec. 31, 2016

Stock price per share

$ 1.75

Employment Agreements Two [Member]

Commitments and Contingencies (Textual)

New shares issued during the period, shares

25,000

Vesting date of options

Dec. 31, 2016

Stock price per share

$ 1.75

Advisory Board Agreements [Member]

Commitments and Contingencies (Textual)

Description of agreement

On February 11, 2016, the Company entered into an advisory board agreement with John Brenkus, effective June 1, 2016 (the ("Effective Date"). The term of the agreement is for a period of 24 months commencing on the Effective Date.

Agreement term

24 months

New shares issued during the period, shares

25,000

Supply Agreement [Member]

Commitments and Contingencies (Textual)

Description of agreement

As consideration for its designation as IMG's "Official Supplier" the Company must pay IMG three installments of $208,000 during the Term as specified in the Agreement.

Accounts payable and accrued expenses

$ 39,126

$ 39,126

$ 39,126

Second exclusive Financial Advisory and Investment Banking Agreement [Member]

Commitments and Contingencies (Textual)

Vesting period

4 months

Monthly fee

$ 10,000

Vesting date of options

Jan. 1, 2019

Owed fees

$ 76,250

$ 17,500

Second exclusive Financial Advisory and Investment Banking Agreement [Member] | 2015 Financing [Member]

Commitments and Contingencies (Textual)

Monthly fee

$ 2,000,000

Second exclusive Financial Advisory and Investment Banking Agreement [Member] | February 1, 2016 through July 1, 2016 [Member]

Commitments and Contingencies (Textual)

Vesting period

6 months

Monthly fee

$ 5,000

Second exclusive Financial Advisory and Investment Banking Agreement [Member] | August 1, 2016 through January 1, 2017 [Member]

Commitments and Contingencies (Textual)

Vesting period

6 months

Monthly fee

$ 7,500

Second exclusive Financial Advisory and Investment Banking Agreement [Member] | February 1, 2017 through January 1, 2018 [Member]

Commitments and Contingencies (Textual)

Vesting period

12 months

Monthly fee

$ 10,000

Second exclusive Financial Advisory and Investment Banking Agreement [Member] | February 1, 2018 through January 1, 2019 [Member]

Commitments and Contingencies (Textual)

Vesting period

12 months

Monthly fee

$ 13,700